Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM	10-Q



☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2020



☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 1-13270

FLOTEK INDUSTRIES, INC.

(Exact name of registrant as specified in its charter)



Delaware			90-0023731
(State of other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)

8846 N. Sam Houston Parkway W.	Houston,	TX	77064

(Address of principal executive offices)			(Zip Code)

(713) 849-9911

(Registrant’s telephone number, including area code)



Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.0001 par value	FTK	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer	☐	Accelerated Filer	☒

Non-accelerated filer	☐	Smaller reporting company	☒

		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of August 4, 2020, there were 71,306,770 outstanding shares of Flotek Industries, Inc. common stock, $0.0001 par value.

TABLE OF CONTENTS




PART I—FINANCIAL INFORMATION

Item 1.	Financial Statements	3
	Unaudited Condensed Consolidated Balance Sheets at June 30, 2020 and December 31, 2019	3
	Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2020 and 2019	4
	Unaudited Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2020 and 2019	5
	Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2020 and 2019	6
	Unaudited Condensed Consolidated Statement of Stockholders’ Equity for the three and six months ended June 30, 2020 and 2019	8
	Notes to Unaudited Condensed Consolidated Financial Statements	10

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	31

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	39

Item 4.	Controls and Procedures	39

PART II—OTHER INFORMATION

Item 1.	Legal Proceedings	41

Item 1A.	Risk Factors	41

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	42

Item 3.	Defaults Upon Senior Securities	42

Item 4.	Mine Safety Disclosures	42

Item 5.	Other Information	42

Item 6.	Exhibits	43

SIGNATURES		44

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

FLOTEK INDUSTRIES, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)



	June 30, 2020			December 31, 2019
ASSETS
Current assets:
Cash and cash equivalents	$	59,926		$	100,575
Restricted cash	664			663
Accounts receivable, net of allowance for doubtful accounts of $1,383 and $1,527 at June 30, 2020 and December 31, 2019, respectively	8,108			15,638
Inventories, net	23,338			23,210
Income taxes receivable	6,846			631
Other current assets	2,407			13,191
Total current assets	101,289			153,908
Property and equipment, net	8,017			39,829
Operating lease right-of-use assets	2,422			16,388
Goodwill	17,522			—
Deferred tax assets, net	152			152
Other intangible assets, net	12,777			20,323
Other long-term assets	17			—
TOTAL ASSETS	$	142,196		$	230,600
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	7,876		$	16,231
Accrued liabilities	10,474			24,552
Income taxes payable	12			—
Current portion of long-term debt	2,527			—
Current portion of operating lease liabilities	654			486
Current portion of finance lease liabilities	57			55
Total current liabilities	21,600			41,324
Long-term debt, less current portion	3,144			—
Deferred revenue, long-term	111			—
Long-term operating lease liabilities	8,497			16,973
Long-term finance lease liabilities	127			158
Deferred tax liabilities, net	11			116
Total liabilities	33,490			58,571
Commitments and contingencies (See Note 19)
Stockholders’ equity:
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding	—			—
Common stock, $0.0001 par value, 140,000,000 shares authorized; 77,626,135 shares issued and 73,166,719 shares outstanding at June 30, 2020; 63,656,897 shares issued and 59,511,416 shares outstanding at December 31, 2019	7			6
Additional paid-in capital	357,980			347,564
Accumulated other comprehensive income	51			181
Retained earnings (accumulated deficit)	(215,766		)	(142,238		)
Treasury stock, at cost; 4,459,416 and 4,145,481 shares at June 30, 2020 and December 31, 2019, respectively	(33,566		)	(33,484		)
Total stockholders’ equity	108,706			172,029
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	142,196		$	230,600

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

FLOTEK INDUSTRIES, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)



	Three months ended June 30,						Six months ended June 30,
	2020			2019			2020			2019
Revenue	$	8,880		$	34,692		$	28,296		$	77,949
Costs and expenses:
Operating expenses (excluding depreciation and amortization)	11,632			38,121			34,473			82,089
Corporate general and administrative	5,395			6,054			9,888			13,335
Depreciation and amortization	468			2,119			2,659			4,379
Research and development	1,638			2,076			4,193			4,360
(Gain) loss on disposal of long-lived assets	(22		)	(4		)	(55		)	1,093
Impairment of fixed and long-lived assets	—			—			57,454			—
Total costs and expenses	19,111			48,366			108,612			105,256
Loss from operations	(10,231		)	(13,674		)	(80,316		)	(27,307		)
Other (expense) income:
Gain on lease termination	576			—			576			—
Interest expense	(16		)	(16		)	(20		)	(2,013		)
Other income, net	78			693			31			800
Total other expense, net	638			677			587			(1,213		)
Loss before income taxes	(9,593		)	(12,997		)	(79,729		)	(28,520		)
Income tax benefit	32			192			6,201			503
Loss from continuing operations	(9,561		)	(12,805		)	(73,528		)	(28,017		)
(Loss) income from discontinued operations, net of tax	—			(1,608		)	—			44,466
Net (loss) income	$	(9,561	)	$	(14,413	)	$	(73,528	)	$	16,449

Basic earnings (loss) per common share:
Continuing operations	$	(0.14	)	$	(0.22	)	$	(1.17	)	$	(0.48	)
Discontinued operations, net of tax	—			(0.03		)	—			0.76
Basic earnings (loss) per common share	$	(0.14	)	$	(0.25	)	$	(1.17	)	$	0.28

Diluted earnings (loss) per common share:
Continuing operations	$	(0.14	)	$	(0.22	)	$	(1.17	)	$	(0.48	)
Discontinued operations, net of tax	—			(0.03		)	—			0.76
Diluted earnings (loss) per common share	$	(0.14	)	$	(0.25	)	$	(1.17	)	$	0.28

Weighted average common shares:
Weighted average common shares used in computing basic earnings (loss) per common share	66,035			58,608			62,828			58,491
Weighted average common shares used in computing diluted earnings (loss) per common share	66,035			58,608			62,828			58,491

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

FLOTEK INDUSTRIES, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands)



	Three months ended June 30,						Six months ended June 30,
	2020			2019			2020			2019
Loss from continuing operations	$	(9,561	)	$	(12,805	)	$	(73,528	)	$	(28,017	)
(Loss) income from discontinued operations, net of tax	—			(1,608		)	—			44,466
Net (loss) income	(9,561		)	(14,413		)	(73,528		)	16,449
Other comprehensive (loss) income:
Foreign currency translation adjustment	(7		)	24			(130		)	118
Comprehensive (loss) income	$	(9,568	)	$	(14,389	)	$	(73,658	)	$	16,567

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

FLOTEK INDUSTRIES, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)



	Six months ended June 30,
	2020			2019
Cash flows from operating activities:
Net (loss) income attributable to Flotek Industries, Inc.	$	(73,528	)	$	16,449
Less: Income from discontinued operations, net of tax	—			44,466
Loss from continuing operations	(73,528		)	(28,017		)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization	2,659			4,379
Amortization of deferred financing costs	—			1,428
Provision for doubtful accounts	474			102
Provision for excess and obsolete inventory	529			—
Impairment of right-of-use assets	7,434			—
Impairment of fixed assets	30,178			—
Impairment of intangible assets	19,842			—
(Gain)/loss on disposal of long-lived assets	(631		)	1,093
Non-cash lease expense	242			464
Stock compensation expense	1,521			1,669
Deferred income tax provision	(105		)	17,855
Reduction in tax benefit related to share-based awards	—			24
Changes in current assets and liabilities:
Accounts receivable, net	7,252			6,289
Inventories, net	6,418			554
Income taxes receivable	(6,351		)	(281		)
Other current assets	1,715			(1,990		)
Other long-term assets	—			3,286
Accounts payable	(10,229		)	(4,157		)
Accrued liabilities	(16,755		)	(10,216		)
Income taxes payable	119			1,182
Interest payable	—			(8		)
Net cash used in operating activities	(29,216		)	(6,344		)
Cash flows from investing activities:
Capital expenditures	(42		)	(767		)
Proceeds from sale of business	9,844			152,217
Proceeds from sale of assets	66			140
Purchase of JP3, net of cash acquired	(26,284		)	—
Purchase of patents and other intangible assets	(8		)	(227		)
Net cash (used in) provided by investing activities	(16,424		)	151,363
Cash flows from financing activities:
Borrowings on revolving credit facility	—			42,984
Repayments on revolving credit facility	—			(92,715		)
Proceeds from Paycheck Protection Program loan	4,798			—
Purchase of treasury stock related to share-based awards	(82		)	(142		)
Proceeds from sale of common stock	358			—
Payments for finance leases	(51		)	(38		)
Net cash provided by (used in) financing activities	5,023			(49,911		)
Discontinued operations:
Net cash used in operating activities	—			(321		)
Net cash provided by investing activities	—			337
Net cash flows provided by discontinued operations	—			16
Effect of changes in exchange rates on cash and cash equivalents	(31		)	2

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.



Net (decrease) increase in cash and cash equivalents and restricted cash	(40,648		)	95,126
Cash and cash equivalents at the beginning of period	100,575			3,044
Restricted cash at the beginning of period	663			—
Cash and cash equivalents and restricted cash at beginning of period	101,238			3,044
Cash and cash equivalents at end of period	59,926			97,509
Restricted cash at the end of period	664			661
Cash and cash equivalents and restricted cash at the end of period	$	60,590		$	98,170

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

FLOTEK INDUSTRIES, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands)



	Three months ended June 30, 2020
	Common Stock			Treasury Stock					Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)			Retained Earnings (Accumulated Deficit)			Total Stockholders’ Equity
	Shares Issued	Par Value		Shares		Cost			Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)			Retained Earnings (Accumulated Deficit)			Total Stockholders’ Equity
Balance, March 31, 2020	64,338	$	6	4,395		$	(33,529	)	$	348,375	$	58		$	(206,205	)	$	108,705
Net loss	—	—		—		—			—		—			(9,561		)	(9,561		)
Foreign currency translation adjustment	—	—		—		—			—		(7		)	—			(7		)
Stock issued under employee stock purchase plan	—	—		(12	)	—			9		—			—			9
Restricted stock granted	1,788	—		—		—			—		—			—			—
Restricted stock forfeited	—	—		37		—			—		—			—			—
Treasury stock purchased	—	—		39		(37		)	—		—			—			(37		)
Stock compensation expense	—	—		—		—			1,059		—			—			1,059
Stock issued in JP3 acquisition	11,500	1		—		—			8,537		—			—			8,538
Balance, June 30, 2020	77,626	$	7	4,459		$	(33,566	)	$	357,980	$	51		$	(215,766	)	$	108,706



	Three months ended June 30, 2019
	Common Stock			Treasury Stock				Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Retained Earnings (Accumulated Deficit)			Total Stockholders’ Equity
	Shares Issued	Par Value		Shares	Cost			Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Retained Earnings (Accumulated Deficit)			Total Stockholders’ Equity
Balance, March 31, 2019	62,199	$	6	3,845	$	(33,368	)	$	344,004	$	125	$	(77,461	)	$	233,306
Net income	—	—		—	—			—		—		(14,413		)	(14,413		)
Foreign currency translation adjustment	—	—		—	—			—		24		—			24
Restricted stock granted	757	—		—	—			—		—		—			—
Restricted stock forfeited	—	—		99	—			—		—		—			—
Treasury stock purchased	—	—		4	(10		)	—		—		—			(10		)
Stock compensation expense	—	—		—	—			1,213		—		—			1,213
Balance, June 30, 2019	62,956	$	6	3,948	$	(33,378	)	$	345,217	$	149	$	(91,874	)	$	220,120

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

FLOTEK INDUSTRIES, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands)



	Six months ended June 30, 2020
	Common Stock			Treasury Stock					Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)			Retained Earnings (Accumulated Deficit)			Total Stockholders’ Equity
	Shares Issued	Par Value		Shares		Cost			Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)			Retained Earnings (Accumulated Deficit)			Total Stockholders’ Equity
Balance, December 31, 2019	63,657	$	6	4,145		$	(33,484	)	$	347,564	$	181		$	(142,238	)	$	172,029
Net loss	—	—		—		—			—		—			(73,528		)	(73,528		)
Foreign currency translation adjustment	—	—		—		—			—		(130		)	—			(130		)
Stock issued under employee stock purchase plan	—	—		(25	)	—			20		—			—			20
Restricted stock granted	2,469	—		—		—			338		—			—			338
Restricted stock forfeited	—	—		278		—			—		—			—			—
Treasury stock purchased	—	—		61		(82		)	—		—			—			(82		)
Stock compensation expense	—	—		—		—			1,521		—			—			1,521
Stock issued in JP3 acquisition	11,500	1		—		—			8,537		—			—			8,538
Balance, June 30, 2020	77,626	$	7	4,459		$	(33,566	)	$	357,980	$	51		$	(215,766	)	$	108,706



	Six months ended June 30, 2019
	Common Stock			Treasury Stock				Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Retained Earnings (Accumulated Deficit)			Total Stockholders’ Equity
	Shares Issued	Par Value		Shares	Cost			Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Retained Earnings (Accumulated Deficit)			Total Stockholders’ Equity
Balance, December 31, 2018	62,163	$	6	3,770	$	(33,237	)	$	343,536	$	31	$	(108,323	)	$	202,013
Net income	—	—		—	—			—		—		16,449			16,449
Foreign currency translation adjustment	—	—		—	—			—		118		—			118
Restricted stock granted	793	—		—	—			—		—		—			—
Restricted stock forfeited	—	—		133	—			—		—		—			—
Treasury stock purchased	—	—		45	(141		)	—		—		—			(141		)
Stock compensation expense	—	—		—	—			1,681		—		—			1,681
Balance, June 30, 2019	62,956	$	6	3,948	$	(33,378	)	$	345,217	$	149	$	(91,874	)	$	220,120

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 — Organization and Significant Accounting Policies

Organization and Nature of Operations

Flotek Industries, Inc. (“Flotek” or the “Company”) is a technology-driven international chemistry and data company that develops and supplies chemistries, services, equipment and data analytics to industrial, commercial and consumer markets.

During the second quarter of 2020, the Company acquired 100% ownership of JP3 Measurement, LLC (“JP3”), a privately-held leading data and analytics technology company, in a cash-and-stock transaction. JP3’s real-time data platforms combine the energy industry’s only field-deployable, inline optical analyzer with proprietary cloud visualization and analytics, targeting an increase of processing efficiencies and valuation of natural gas, crude oil, and refined fuels. The transaction was valued at approximately $36.6 million, as of the transaction closing date, comprised of $25.0 million in cash subject to certain adjustments and contingent consideration and 11.5 million shares in Flotek common stock with an estimated fair value of $8.5 million, net of a discount for marketability due to a lock-up period. The payment of $25.0 million was subject to certain purchase price adjustments, and the total non-equity consideration at closing was comprised of $25.0 million plus net working capital in excess of the target net working capital of $1.9 million and contingent consideration of an estimated $1.2 million for two potential earn-out provisions totaling $5.0 million based on certain stock performance targets.

With the acquisition of JP3, the Company evaluated its segment information and determined that there were two segments: Chemistry Technologies and Data Analytics, which are both supported by its continuing Research & Innovation advanced laboratory capabilities.

The Company’s Chemistry Technologies segment includes specialty chemistries, logistics and technology services. The Company designs, develops, manufactures, packages, distributes, delivers, and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in oil and gas well drilling, cementing, completion, remediation, and stimulation activities designed to maximize recovery in both new and mature fields. Customers of the Chemistry Technologies business segment include major integrated oil and gas companies, oilfield services companies, independent oil and gas companies, pressure-pumping service companies, national and state-owned oil companies, and international supply chain management companies.

In the second quarter of 2020, the Chemistry Technologies segment launched a line of sanitizers and disinfectants for commercial and personal consumer use. These products build on the Company’s historical expertise in chemistry and leverage its infrastructure, personnel, competencies, supply chain, research, and historic consumer market experiences, yielding a competitive product offering in this rapidly growing area. The newly-launched products include hand sanitizers for retail and e-commerce sales and disinfecting liquids for use in and by hospitals, first responders, the travel and hospitality industry, food services, sporting facilities, and other commercial and industrial applications.

The customers of the Data Analytics segment span across the entire market, from production upstream to midstream facilities to refineries and distribution networks. To date, the Data Analytics segment has focused solely on North American markets. The Data Analytics segment provides real-time hydrocarbon composition data that helps its customers generate additional profit by enhancing blending, increasing efficiencies of towers, enabling automation and robotization of fluid handling, and reducing losses due to give-away.

Flotek was initially incorporated under the laws of the Province of British Columbia on May 17, 1985. On October 23, 2001, Flotek changed its corporate domicile to the state of Delaware.

Basis of Presentation

The accompanying Financial Statements reflect all adjustments, in the opinion of management, necessary for fair presentation of the financial condition and results of operations for the periods presented. All such adjustments are normal and recurring in nature. The Financial Statements, including selected notes, have been prepared in accordance with applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and do not include all information and disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for comprehensive financial statement reporting. These interim Financial Statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31,

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

2019 (“2019Annual Report”) as amended by the Amendment No. 2 on Form 10-K/A to the 2019 Annual Report, filed with the SEC on June 11, 2020. A copy of the 2019 Annual Report is available on the SEC’s website, www.sec.gov, under the Company’s ticker symbol (“FTK”) or on Flotek’s website, www.flotekind.com.

All significant intercompany accounts and transactions have been eliminated in consolidation. The Company does not have investments in any unconsolidated subsidiaries.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates.

Potential Impact of COVID-19

On March 11, 2020, the World Health Organization declared the outbreak of the novel coronavirus (“COVID-19”) a global pandemic, which continues to spread throughout the United States and around the world. This outbreak has severely impacted global economic activity, and many countries and many states in the United States have reacted to the outbreak by instituting quarantines, mandating business and school closures and restricting travel. In addition, global oil producers, including the Organization of Petroleum Exporting Countries and other oil producing nations, have experienced disagreements relating to oil production which has led to downward pressure on commodity prices.

The effects of the COVID-19 pandemic, including actions taken by businesses and governments, have resulted in a significant and swift reduction in international and U.S. economic activity. These effects and the volatility in oil prices have materially and adversely affected, and may continue to materially and adversely affect, the demand for oil and natural gas. The Company’s primary markets in Texas are particularly subject to the financial impact of a collapse in oil prices. In the second quarter of 2020, these conditions and the related financial impact have continued and, in some cases, worsened. As a result, the Company has recorded an impairment to property, plant and equipment, intangible assets, and operating right-of-use assets during the first quarter of 2020. In addition, the Company adopted social distancing and work-from-home procedures, which have had and may continue to have an impact on the ability of employees and management of the Company to communicate and work efficiently.

In response to the deteriorating market conditions and anticipating ongoing volatility, the Company has also reduced its cost structure to meet anticipated market activity and reduce the Company’s break-even levels. Among other cost-cutting initiatives:

• The Company’s CEO, John W. Gibson, Jr., reduced his base salary by 20%, and each of the other executive officers reduced his or her salary by 10% , through December 31, 2020 in exchange for restricted stock, effective as of April 1, 2020.

• The board of directors of Flotek approved a 20% reduction in the fees to be paid to the directors, effective as of April 1, 2020.

• The Company consolidated office space by moving all employees at its corporate headquarters into the Houston Global Resource and Innovation Center, (“GRIC”) facility and buying out the remaining term of the corporate headquarters lease for a significant discount, with the move completed by the end of June 2020.

• The Company reduced headcount by 35% on March 30, 2020.

While the full impact of the COVID-19 outbreak is not yet known, we are closely monitoring the effects of the pandemic on commodity demands and on our customers, as well as on our operations and employees. Any future development and effects will be highly uncertain and cannot be predicted, including the scope and duration of the pandemic; further adverse revenue and net income effects; disruptions to our operations; third party providers’ ability to support our operations; customer shutdowns of oil and gas exploration and production; the effectiveness of our work from home arrangements; employee impacts from illness, school closures and other community response measures; any actions taken by governmental authorities and other third parties in response to the pandemic; and temporary closures of our facilities or the facilities of our customers and suppliers.

Reclassifications

Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did not impact previously reported net loss and stockholders’ equity.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 2 — Recent Accounting Pronouncements

Application of New Accounting Standards

Effective January 1, 2019, the Company adopted the accounting guidance in Accounting Standards Update (“ASU”) No. 2016-02, “Leases.” This standard (ASC 842) requires the recognition of Right-Of-Use (“ROU”) assets and lease liabilities by lessees for those leases classified as operating leases under previous U.S. GAAP (ASC 840). Upon adoption, the Company recorded operating lease ROU assets and corresponding operating lease liabilities, net of deferred rent, representing the present value of future lease payments under operating leases with terms of greater than twelve months. The adoption of this standard did not have a material impact on the consolidated statements of operations or cash flows. Refer to Note 5 — “Leases” for further information surrounding adoption of this new standard.

Effective January 1, 2019, the Company adopted ASU No. 2018-02, “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” This standard allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the 2017 Tax Cuts and Jobs Act. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures.

Effective January 1, 2019, the Company adopted ASU No. 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting.” This standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures.

New Accounting Requirements and Disclosures

Effective January 1, 2020, the Company adopted ASU No. 2018-13, “Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement.” This standard removes, modifies, and adds additional requirements for disclosures related to fair value measurement in ASC 820. The pronouncement is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted in any interim period. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures.

New Accounting Standards to be Adopted

The Financial Accounting Standards Board (“FASB”) issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This standard removes specific exceptions to the general principles in Topic 740. The pronouncement is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years, with early adoption permitted for public companies for periods in which financial statements have not yet been issued. The Company is currently evaluating the impact of this standard on the consolidated financial statements and related disclosures.

The FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments.” This standard replaces the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The pronouncement is effective for smaller reporting companies for fiscal years beginning after December 15, 2022. The Company is currently evaluating the impact of this standard on the consolidated financial statements and related disclosures.

Note 3 — Acquisition of JP3 Measurement LLC

During the second quarter of 2020, the Company acquired 100% ownership of JP3, a privately-held data and analytics technology company, in a cash-and-stock transaction. JP3’s real-time data platforms combine the energy industry’s only field-deployable, inline optical analyzer with proprietary cloud visualization and analytics, targeting an increase of processing efficiencies and valuation of natural gas, crude oil, and refined fuels. The transaction was valued at approximately $36.6 million, as of the transaction closing date, comprised of $25.0 million in cash, subject to certain adjustments and contingent consideration as described below, and 11.5 million shares in Flotek common stock with an estimated fair value of $8.5 million, net of a discount for marketability due to a lock-up period. The payment of $25.0 million was subject to certain purchase price adjustments, and the total non-equity consideration at closing was comprised of $25.0 million plus net working capital in excess of the target net working capital of $1.9 million and contingent consideration of an estimated $1.2 million for two potential earn-out provisions totaling $5.0 million based on certain stock performance targets.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The following table summarizes the fair value of JP3’s assets acquired as of the closing date of May 18, 2020 (in thousands) :



Tradenames and trademarks	$	1,100
Technology and know-how	5,000
Customer relationships	6,800
Inventory	7,100
Cash	604
Net working capital, net of cash and inventory	(1,063		)
Fixed assets	426
Long-term debt assumed and other assets (liabilities)	(893		)
Goodwill	17,522
Net assets acquired	$	36,596

These amounts are preliminary in nature and subject to adjustments from the final determination of working capital, which could be material. Any necessary adjustments are expected to be finalized within one year from the date of acquisition. The Company recorded transaction costs of $0.5 million for professional services including legal, accounting, and other professional or consulting fees to the Company’s Operating expenses (excluding depreciation and amortization) in the consolidated statement of income for the three and six months ended June 30, 2020.

Pro forma information for JP3 is not provided as the impact is not considered material.

Note 4 — Discontinued Operations

On January 10, 2019, the Company entered into a Share Purchase Agreement with Archer-Daniels-Midland Company (“ADM”) for the sale of all of the shares representing membership interests in its wholly owned subsidiary, Florida Chemical Company, LLC (“FCC”), which represented the Consumer and Industrial Chemistry Technologies (“CICT”) segment.

Effective February 28, 2019, the Company completed the sale of FCC to ADM for $175.0 million in cash consideration, with $4.4 million temporarily held in escrow by ADM for post-closing working capital adjustments for up to 90 days and $13.1 million temporarily held in escrow to satisfy potential indemnification claims by ADM with anticipated releases at 6 months, 12 months, and 15 months. Pursuant to the terms of the Share Purchase Agreement, Flotek Chemistry, LLC (“Flotek Chemistry”), a wholly owned subsidiary of the Company, entered into a supply agreement with FCC who will supply terpene at specified prices for specified quantities. The agreement will expire on December 31, 2023.

As of December 31, 2019, the Company concluded that the original long-term supply agreement met the definition of a loss contract. As such, the Company recognized a loss of $19 million as of December 31, 2019, capped by the price paid for the terpene supply agreement amendment, executed in February 2020, which aligned purchase commitments to expected usage for blended products as of December 31, 2019. The Company has classified the assets, liabilities, and results of operations for this segment as “Discontinued Operations” for all periods presented.

Pursuant to the post-closing working capital dispute resolution procedures set forth in the Share Purchase Agreement, the Company and ADM engaged a neutral third party auditor to help reach agreement on the final post-closing working capital adjustment. In February 2020, the third party auditor ruled in favor of awarding ADM the entire disputed amount. As a result, the working capital adjustment escrow balance was released to ADM and a corresponding reduction was made to the gain on sale of business as of December 31, 2019.

On February 26, 2020, Flotek Chemistry entered into an amendment to the terpene supply agreement between Flotek Chemistry and FCC. Pursuant to the terms and conditions of the amendment, the terpene supply agreement is amended to, among other things, (a) reduce the minimum quantity of terpene that Flotek Chemistry is required to purchase by approximately 3/4ths in 2020 and by approximately half in each of 2021, 2022 and 2023, (b) provide a fixed per pound price for terpene in 2020, (c) reduce the maximum amount of terpene subject to the terpene supply agreement by approximately 1/3rd, and (d) change the payment terms to net 45 days. In order to make the terms and conditions of the amendment to the terpene supply agreement effective, Flotek Chemistry made a one-time payment in February 2020 of $15.8 million to ADM. The expense associated with the terpene supply agreement amendment payment was recorded as a loss on contract purchase commitments, reported in operating expenses in continuing operations in December 2019.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the six months ended June 30, 2020, the Company recognized a loss of $0.8 million associated with the amended terpene supply agreement due to adjustments in the Company’s expected usage of terpene in blended products in 2020.

During the first quarter 2020, as scheduled, $3.3 million of the indemnity escrow was released to the Company. During the second quarter 2020 the remaining indemnity escrow of $6.6 million was released to the Company.

The following summarized financial information has been segregated from continuing operations and reported as Discontinued Operations for the three and six months ended June 30, 2020 and 2019 (in thousands):



	Three months ended June 30,					Six months ended June 30,
	2020		2019			2020		2019
Consumer and Industrial Chemistry Technologies
Revenue	$	—	$	—		$	—	$	10,877
Operating expenses	—		—			—		(11,447		)
Research and development	—		—			—		(69		)
(Loss) income from operations	—		—			—		(639		)
Other income	—		—			—		35
Gain on sale of business	—		(2,100		)	—		64,934
(Loss) Income before income taxes	—		(2,100		)	—		64,330
Income tax benefit (expense)	—		492			—		(19,864		)
Net (loss) income from discontinued operations	$	—	$	(1,608	)	$	—	$	44,466

Note 5 — Leases

During the first quarter 2020, the Company made the decision to cease use of the corporate headquarters leased offices and move corporate employees to the GRIC during second quarter of 2020. In addition, the lease liability and corresponding ROU assets for the corporate headquarters and GRIC were remeasured to remove the anticipated term extensions as it was determined the Company was no longer reasonably certain to utilize the extension at the GRIC. The remeasurement resulted in adjustments to lease liabilities and ROU assets totaling of $6.2 million each as of March 31, 2020.

In addition, during the three months ended March 31, 2020, the Company recorded an impairment of the ROU assets totaling $7.4 million. See Note 10 - Impairment of Fixed and Long-lived Assets for further discussion of the impairment charge booked in the first quarter 2020.

During the second quarter of 2020, the Company terminated the lease of the corporate headquarters office in exchange for a one-time payment of $1.0 million and moved all employees to the GRIC facility effective as of June 29, 2020. As a result of terminating the corporate headquarters office lease and making the one-time payment, the Company recorded a gain on lease termination of $0.6 million million recorded in gain on lease termination.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The components of lease expense and supplemental cash flow information are as follows (in thousands):



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Operating lease expense	$	283	$	653	$	854	$	1,306
Finance lease expense:
Amortization of right-of-use assets	4		220		9		220
Interest on lease liabilities	5		3		9		3
Total finance lease expense	9		223		18		223
Short-term lease expense	54		32		86		75
Total lease expense	$	346	$	908	$	958	$	1,604

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	1,411	$	583	$	1,024	$	1,165
Operating cash flows from finance leases	5		3		9		3
Financing cash flows from finance leases	14		38		51		38

Maturities of lease liabilities are as follows (in thousands):



Years ending December 31,	Operating Leases			Finance Leases
2020 (excluding the six months ended June 30, 2020)	$	617		$	33
2021	1,330			70
2022	1,283			47
2023	1,311			39
2024	1,341			23
Thereafter	8,185			—
Total lease payments	$	14,067		$	212
Less: Interest	(4,916		)	(28		)
Present value of lease liabilities	$	9,151		$	184

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Supplemental balance sheet information related to leases is as follows (in thousands):



	June 30, 2020			December 31, 2019
Operating Leases
Operating lease right-of-use assets	$	2,422		$	16,388

Current portion of operating lease liabilities	$	654		$	486
Long-term operating lease liabilities	8,497			16,973
Total operating lease liabilities	$	9,151		$	17,459

Finance Leases
Property and equipment	$	147		$	293
Accumulated depreciation	(18		)	(28		)
Property and equipment, net	$	129		$	265

Current portion of finance lease liabilities	$	57		$	55
Long-term finance lease liabilities	127			158
Total finance lease liabilities	$	184		$	213

Weighted Average Remaining Lease Term
Operating leases	10.1 years			16.6 years
Finance leases	4.1 years			4.6 years

Weighted Average Discount Rate
Operating leases	8.9		%	8.9		%
Finance leases	8.5		%	9.0		%

Note 6 — Revenue from Contracts with Customers

Revenues are recognized when control of the promised goods or services is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. In recognizing revenue for products and services, the Company determines the transaction price of purchase orders or contracts with customers, which may consist of fixed and variable consideration. Determining the transaction price may require significant judgment by management, which includes identifying performance obligations, estimating variable consideration to include in the transaction price, and determining whether promised goods or services are distinct within the context of the contract. Variable consideration typically consists of product returns and is estimated based on the amount of consideration the Company expects to receive. Revenue accruals are recorded on an ongoing basis to reflect updated variable consideration information.

The vast majority of the Chemistry Technologies’ segment products are sold at a point in time and service contracts are short-term in nature. Sales are billed on a monthly basis with payment terms customarily 30-45 days for domestic and 60 day for international from invoice receipt. In addition, sales taxes are excluded from revenues.

The Data Analytics segment provides services over a period of time and for those services, the revenues are recognized over time.

Disaggregation of Revenue

The Company has disaggregated revenues by product sales (point-in-time revenue recognition) and service revenue (over-time revenue recognition), where product sales accounted for over 90% of total revenue for the three and six months ended June 30, 2020 and 2019.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The Company differentiates revenue and operating expenses (excluding depreciation and amortization) based on whether the source of revenue is attributable to products or services. Revenue and operating expenses (excluding depreciation and amortization) disaggregated by revenue source are as follows (in thousands):



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Revenue:
Products	$	8,176	$	33,632	$	26,976	$	75,703
Services	704		1,060		1,320		2,246
	$	8,880	$	34,692	$	28,296	$	77,949
Operating expenses (excluding depreciation and amortization):
Products	$	11,278	$	37,613	$	33,825	$	81,062
Services	354		508		648		1,027
	$	11,632	$	38,121	$	34,473	$	82,089

Arrangements with Multiple Performance Obligations

The Company’s contracts with customers may include multiple performance obligations. For such arrangements, the total transaction price is allocated to each performance obligation in an amount based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. Standalone selling prices are generally determined based on the prices charged to customers (“observable standalone price”) or an expected cost plus a margin approach. For combined products and services within a contract, the Company accounts for individual products and services separately if they are distinct (i.e. if a product or service is separately identifiable from other items in the contract and if a customer can benefit from it on its own or with other resources that are readily available to the customer). The consideration is allocated between separate products and services within a contract based on the prices at the observable standalone price. For items that are not sold separately, the expected cost plus a margin approach is used to estimate the standalone selling price of each performance obligation.

Contract Balances

Under revenue contracts for both products and services, customers are invoiced once the performance obligations have been satisfied, at which point payment is unconditional. The Company has an immaterial amount of contract liabilities associated to incomplete performance obligations.

Note 7 — Supplemental Cash Flow Information

Supplemental cash flow information is as follows (in thousands):



	Six months ended June 30,
	2020		2019
Supplemental cash payment information:
Interest paid	$	20	$	594
Income taxes paid, net of refunds	149		627
Supplemental schedule of non-cash investing and financing activities:
Equity issued - acquisition of JP3	8,538		—

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 8 — Inventories

Inventories are as follows (in thousands):



	June 30, 2020			December 31, 2019
Raw materials	$	4,810		$	4,339
Finished goods	20,155			24,569
Inventories	24,965			28,908
Less reserve for excess and obsolete inventory	(1,627		)	(5,698		)
Inventories, net	$	23,338		$	23,210

The Company periodically reviews the value of items in inventory and provides write-downs or write-offs of inventory based on an assessment of market values. Write-downs of inventory are charged to cost of goods sold. Low-turn inventory or inventory in excess of management's estimated usage requirement are analyzed for sale before conducting an analysis to write off or write down inventory to the estimated market value if those amounts are determined to be less than cost.

Note 9 — Property and Equipment

Property and equipment are as follows (in thousands):



	June 30, 2020			December 31, 2019
Land	$	3,282		$	4,440
Buildings and leasehold improvements	6,048			38,741
Machinery and equipment	7,227			27,694
Furniture and fixtures	643			1,671
Transportation equipment	1,190			1,440
Computer equipment and software	1,296			3,348
Property and equipment	19,686			77,334
Less accumulated depreciation	(11,669		)	(37,505		)
Property and equipment, net	$	8,017		$	39,829

Depreciation expense totaled $0.3 million and $1.6 million for the three months ended June 30, 2020 and 2019, and $2.0 million and $3.4 million for the six months ended June 30, 2020 and 2019.

During the six months ended June 30, 2020 an impairment was recognized for $30.2 million. No impairment was recognized for the three months ended June 30, 2020.

Note 10 — Impairment of Fixed and Long-lived Assets

During the first quarter 2020, the price of crude oil declined by over 50%, trading below $25 per barrel, causing a significant disruption across the industry, which began to negatively impact the Company’s results of operations. These declines of results of operations were driven by an oversupply of oil, insufficient storage, and demand destruction resulting from the reaction to COVID-19. Based on these factors, the Company concluded that a triggering event occurred and, accordingly, an interim quantitative impairment test was performed as of March 31, 2020.

Using the income approach, the fair value of the reporting unit was determined based on the present value of future cash flows. The Company utilized internal forecast trends and potential growth rates to estimate future cash flows of the asset group. Based on the results of the quantitative assessment, the Company concluded the carrying value of the asset group exceeded its fair value as of March 31, 2020 and an impairment loss of $57.5 million was recorded as a result of the adverse effect of the COVID-19 pandemic and the related negative impact on oil and natural gas prices on projections of future cash flows.

The Company recorded impairment charges during the six months ended June 30, 2020 as follows (in thousands):

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS



Property and equipment, net	$	30,178
Operating lease right-of-use assets	7,434

Other Intangibles:
Patents	9,902
Customer Lists	9,165
Intangibles assets in progress	596
Trademarks and brand names	179
Total Other Intangibles	19,842

Total Impairment of fixed and long-lived assets	$	57,454

With the acquisition of JP3, the Company evaluated its segment information and determined that there were two segments: Chemistry Technologies and Data Analytics, which are both supported by its Research & Innovation advanced laboratory capabilities.

Note 11 - Goodwill

Goodwill associated with the acquisition of JP3 on May 18, 2020 is as follows (in thousands):



Goodwill at December 31, 2019	$	—
Goodwill from acquisition of JP3	17,522
Goodwill at June 30, 2020	$	17,522

Note 12 — Other Intangible Assets

Other intangible assets are as follows (in thousands):



	June 30, 2020				December 31, 2019
	Cost		Accumulated Amortization		Cost		Accumulated Amortization
Finite-lived intangible assets:
Patents and technology	$	5,000	$	55	$	17,493	$	6,715
Customer lists	6,800		55		15,367		6,013
Trademarks and brand names	1,100		13		1,351		1,160
Total finite-lived intangible assets	$	12,900	123		$	34,211	13,888

Carrying value:
Other intangible assets, net	$	12,777			$	20,323

Amortization of finite-lived intangible assets acquired totaled $0.1 million and $0.5 million for the three months and six months ended June 30, 2019 and 2019 respectively.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 13 — Earnings (Loss) Per Share

Basic earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding combined with dilutive common share equivalents outstanding, if the effect is dilutive.

Potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and six months ended June 30, 2020 and 2019, since including them would have an anti-dilutive effect on loss per share due to the net loss incurred during the periods. Securities convertible into shares of common stock that were not considered in the diluted loss per share calculations were 0.4 million restricted stock units and 4.0 million stock options for the three and six months ended June 30, 2020 and 0.7 million restricted stock units for the three and six months ended June 30, 2019.

Note 14 — Fair Value Measurements

Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes financial assets and liabilities into the three levels of the fair value hierarchy. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value and bases categorization within the hierarchy on the lowest level of input that is available and significant to the fair value measurement.


•	Level 1 — Quoted prices in active markets for identical assets or liabilities;


•	Level 2 — Observable inputs other than Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and


•	Level 3 — Significant unobservable inputs that are supported by little or no market activity or that are based on the reporting entity’s assumptions about the inputs.

Fair Value of Other Financial Instruments

The carrying amounts of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and Flotek’s Payroll Protection Program (“PPP”) loan approximate fair value due to the short-term nature of these accounts.

Liabilities Measured at Fair Value on a Recurring Basis

The following tables present the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2020 and December 31, 2019, and the level within the fair value hierarchy:



							Balance at June 30,								Balance at December 31,
	Level 1		Level 2		Level 3		2020		Level 1		Level 2		Level 3		2019
Contingent consideration	$	—	$	—	$	1,200	$	1,200	$	—	$	—	$	—	$	—

There were no transfers in or out of either Level 1, Level 2, or Level 3 fair measurements during the periods ending June 30, 2020 and December 31, 2019.

Assets Measured at Fair Value on a Nonrecurring Basis

The Company’s non-financial assets, including property and equipment, and other intangible assets are measured at fair value on a non-recurring basis and are subject to fair value adjustment in certain circumstances. During the three months ended March 31, 2020, the Company recorded an impairment of $57.5 million for impairment on long-lived assets. Management inputs used in fair value measurement were classified as Level 3.

The fair values of the JP3 long-lived assets, and intangibles were determined using the income approach. The fair value of the JP3 contingent consideration was determined using a Monte Carlo simulation. The fair value of the JP3 inventory was determined using the comparative sales method. The fair value measurements were primarily based on significant inputs that are not observable in the market and thus represent a Level 3 measurement, other than cash and working capital accounts which carrying amounts were determined to approximate fair value due to their short-term nature.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

During the quarter ended June 30, 2020, the Company assumed long-term debt of $0.9 million comprised of the PPP loan held by JP3. Management inputs used in fair value measurement were classified as Level 3.

Level 3 Rollforward for Assets and Liabilities Measured at Fair Value on a Recurring Basis

In conjunction with the acquisition of JP3, the Company recorded contingent consideration of $1.2 million. Management inputs used in the fair value measurement were classified as Level 3. The following table presents the changes in contingent consideration balances classified as Level 3 balances for the three and six months ended June 30, 2020 and 2019:



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Balance - beginning of period	$	—	$	—	$	—	$	—
Additions / issuances	1,200		—		1,200		—
Gains (losses) recognized in earnings	—		—		—		—
Payments	—		—		—		—
Balance - end of period	$	1,200	$	—	$	1,200	$	—

Note 15 — Debt

In April 2020, the Company received a $4.8 million loan, under the PPP, which was created through the Coronavirus Aid, Relief, and Economic Act (“CARES Act”) and is administered by the U.S. Small Business Administration (“SBA”). The loans have a fixed interest rate of 1%, mature in two years and payments are deferred for six months. In addition, in connection with the acquisition of JP3, the Company assumed a PPP loan of $0.9 million

A portion of the loans are eligible for forgiveness by the SBA depending on the extent of proceeds used for payroll costs and other designated expenses incurred for up to 24 weeks following loan origination, subject to adjustments for headcount reductions and compensation limits and provided that at least 60% of the eligible costs incurred are used for payroll. Receipt of these funds required the Company to, in good faith, certify that the current economic uncertainty made the loan request necessary to support ongoing operations of the Company. This certification further requires the Company to take into account current business activity and the ability to access other sources of liquidity sufficient to support ongoing operations in a manner that is not significantly detrimental to the business. As of June 30, 2020, the Company has not applied for or estimated the potential forgiveness on the PPP loans. The receipt of these funds, and the forgiveness of the loan attendant to these funds, is dependent on the Company having initially qualified for the loan and qualifying for the forgiveness of such loan based on our future adherence to the forgiveness criteria. The term of the Company’s PPP Loan is two years. The annual interest rate on the PPP Loan is 1% and no payments of principal or interest are due during the six-month period beginning on the date of the PPP Loan. The PPP Loan is subject to any new guidance and new requirements released by the Department of the Treasury who has recently indicated that all companies that have received funds in excess of $2.0 million will be subject to a government (Small Business Administration) audit to further ensure PPP loans are limited to eligible borrowers in need.

Long-term debt, including current portion is as follows (in thousands):

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS



	June 30, 2020
Current Portion of Long-Term Debt
Flotek PPP Loan	$	2,138
JP3 PPP Loan	389
Total current portion of long-term debt	$	2,527

Long-term debt:
Flotek PPP Loan	$	2,660
JP3 PPP Loan	484
Total long-term debt	$	3,144

Note 16 — Income Taxes

A reconciliation of the U.S. federal statutory tax rate to the Company’s effective income tax rate is as follows:



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
U.S. federal statutory tax rate	21.0	%	21.0	%	21.0	%	21.0	%
State income taxes, net of federal benefit	0.4		1.7		—		1.0
Non-U.S. income taxed at different rates	0.9		0.7		0.2		1.0
Reduction in tax benefit related to stock-based awards	0.9		(1.1	)	(0.1	)	(1.8	)
Non-deductible expenses	0.7		—		—		(0.3	)
Research and development credit	0.1		0.4		—		0.6
Increase in valuation allowance	(23.7	)	(20.7	)	(16.0	)	(17.9	)
Effect of tax rate differences of NOL carryback	—		—		2.6		—
Other	—		(0.4	)	—		(0.3	)
Effective income tax rate	0.3	%	1.6	%	7.7	%	3.3	%

On March 27, 2020, the CARES Act was enacted in response to the COVID-19 pandemic. Among other things, the CARES Act provided the ability for taxpayers to carryback a net operating loss (“NOL”) arising in a taxable year beginning after December 31, 2017 and before January 1, 2021 to each of the five years preceding the year of the loss. Based on the Company’s analysis of the extended NOL carryback provision, it recorded a tax receivable of $6.1 million as of March 31, 2020, which was received in July 2020.

Fluctuations in effective tax rates have historically been impacted by permanent tax differences with no associated income tax impact, changes in the valuation allowance, changes in state apportionment factors, including the effect on state deferred tax assets and liabilities, and non-U.S. income taxed at different rates, except for the NOL carryback claim discussed above.

Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted rates and laws that will be in effect when the differences are expected to reverse. ASC 740, Income Taxes, provides for the recognition of deferred tax assets if realization of such assets is more likely than not. In assessing the need for a valuation allowance, the Company considers all available objective and verifiable evidence, both positive and negative, including historical levels of pre-tax income (loss) both on a consolidated basis and tax reporting entity basis, legislative developments, and expectations and risks associated with estimates of future pre-tax income.

As of December 31, 2019, the Company determined that it was more likely than not that it would not realize the benefits of certain deferred tax assets and, therefore, it recorded a $19.9 million valuation allowance against the carrying value of net deferred tax assets, except for deferred tax liabilities related to certain state jurisdictions. As a result of the NOL carryback allowed by the CARES Act, the Company released a valuation allowance of $4.0 million related to its deferred tax assets attributable to its U.S.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

federal NOLs. The Company continues to have a full valuation allowance against net deferred tax assets as it is not more-likely-than-not they will be utilized.

Note 17 — Common Stock

On May 5, 2020, the shareholders of the Company approved an amendment to the Company’s Amended and Restated Certificate of Incorporation, as previously amended, to increase the authorized shares of common stock from 80,000,000 to 140,000,000, par value $0.0001 per share, and 100,000 of preferred stock, par value $0.0001 per share. The additional authorized shares are available for corporate purposes, including acquisitions.

A reconciliation of changes in common shares issued during the six months ended June 30, 2020 is as follows:



Shares issued at December 31, 2019	63,656,897
Issued to purchase JP3	11,500,000
Issued as restricted stock award grants	2,469,238
Shares issued at June 30, 2020	77,626,135

On June 9, 2020, the board of directors of the Company rescinded the authorization to repurchase the Company’s stock that had been previously approved in June 2015.

Note 18 — Business Segment, Geographic and Major Customer Information

Segment Information

Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by chief operating decision-makers in deciding how to allocate resources and assess performance. The operations of the Company are categorized into two reportable segments: Chemistry Technologies and Data Analytics.

The Chemistry Technologies segment includes specialty chemistries and logistics which enable its customers to pursue improved efficiencies in the drilling and completion of their wells.

In the second quarter of 2020, the Company launched a line of sanitizers and disinfectants for commercial and personal consumer use. These products build on the Company’s historical expertise in chemistry and leverage its infrastructure, personnel, competencies, supply chain, research, and historic consumer market experiences yielding a competitive product offering in this rapidly growing segment. The newly launched products, which include hand and surface sanitizers, target growth opportunities across diverse sectors including hospitals, travel and hospitality, food services, e-commerce and retail, sports and entertainment and other industrial and commercial markets.

The Data Analytics segment, created in conjunction with the acquisition of JP3, includes the design, development, production, sale and support of equipment and services that create and provide valuable information about the composition of its energy customers’ hydrocarbon fluids.

The Company evaluates performance based upon a variety of criteria. The primary financial measure is segment operating income. Various functions, including certain sales and marketing activities and general and administrative activities, are provided centrally by the corporate office. Costs associated with corporate office functions, other corporate income and expense items, and income taxes are not allocated to the reportable segment.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Summarized financial information of the reportable segments is as follows (in thousands):



For the three months ended June 30,	Chemistry Technologies			Data Analytics⁽¹⁾			Corporate and Other			Total
2020
Net revenue from external customers	$	7,962		$	918		$	—		$	8,880
Loss from operations, including impairment	(3,596		)	(1,151		)	(5,484		)	(10,231		)
Depreciation and amortization	246			131			91			468
Capital expenditures	—			—			—			—

2019
Net revenue from external customers	$	34,692		$	—		$	—		$	34,692
Loss from operations	(7,651		)	—			(6,023		)	(13,674		)
Depreciation and amortization	1,933			—			186			2,119
Capital expenditures	306			—			—			306



For the six months ended June 30,	Chemistry Technologies			Data Analytics⁽¹⁾			Corporate and Other			Total
2020
Net revenue from external customers	$	27,378		$	918		$	—		$	28,296
Loss from operations, including impairment	(66,257		)	(1,151		)	(12,908		)	(80,316		)
Depreciation and amortization	2,056			131			472			2,659
Capital expenditures	42			—			—			42

2019
Net revenue from external customers	$	77,949		$	—		$	—		$	77,949
Loss from operations	(12,984		)	—			(14,323		)	(27,307		)
Depreciation and amortization	3,718			—			661			4,379
Capital expenditures	767			—			—			767

⁽¹⁾The financial information disclosed above for Data Analytics is for the period May 18, 2020 to June 30, 2020.

Assets of the Company by reportable segments are as follows (in thousands):



	June 30, 2020		December 31, 2019
Chemistry Technologies	$	34,439	$	116,110
Data Analytics	40,922		—
Corporate and Other	66,835		114,490
Total assets	$	142,196	$	230,600

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Geographic Information

Revenue by country is based on the location where services are provided and products are used. No individual country other than the United States (“U.S.”) accounted for more than 10% of revenue. Revenue by geographic location is as follows (in thousands):



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
U.S.	$	6,936	$	31,114	$	22,711	$	69,990
Other countries	1,944		3,578		5,585		7,959
Total	$	8,880	$	34,692	$	28,296	$	77,949

Long-lived assets held in countries other than the U.S. are not considered material to the consolidated financial statements.

Major Customers

Revenue from major customers, as a percentage of consolidated revenue, is as follows:



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Customer A	22.6	%	17.6	%	29.4	%	15.4	%
Customer B	14.0	%	11.0	%	12.5	%	11.3	%
Customer C	*		*		12.3	%	10.7	%

* This customer did not account for more than 10% of revenue during this period.

Note 19 — Commitments and Contingencies

Litigation

The Company is subject to routine litigation and other claims that arise in the normal course of business. Management is not aware of any pending or threatened lawsuits or proceedings that are expected to have a material effect on the Company’s financial position, results of operations or liquidity.

Concentrations and Credit Risk

The majority of the Company’s revenue is derived from its Chemistry Technologies segment which consist predominantly of customers within the oil and gas industry and the sanitizer industry to a lesser extent. Customers within the oil and gas industry include oilfield services companies, integrated oil and natural gas companies, independent oil and natural gas companies, and state-owned national oil companies. Customers within the hand sanitizer industry typically include healthcare institutions such as hospitals, distributors, and various public entities. Given the increase in global demand for sanitizer products due to COVID-19, the Company's concentration of customers is shifting and diversifying, which helps to reduce credit and business risk. Customers within the sanitizer industry are not significantly impacted by commodity prices and typically are financially stable or public institutions.

The Company is subject to concentrations of credit risk within trade accounts receivable, as the Company does not generally require collateral as support for trade receivables. In addition, the majority of the Company’s cash is invested in accounts in two major financial institutions and balances often exceed insurable amounts.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 20 — Related Party Transaction

In January 2017, the Internal Revenue Service (“IRS”) notified the Company that it was examining the Company’s federal tax returns for the year ended December 31, 2014. As a result of this examination, the IRS informed the Company on May 1, 2019 that certain employment taxes related to the compensation of our former CEO, Mr. Chisholm, were not properly withheld in 2014 and proposed an adjustment. Mr. Chisholm’s affiliated companies through which he provided his services have agreed to indemnify the Company for any such taxes, and Mr. Chisholm has executed a personal guaranty in favor of the Company, supporting this indemnification.

At June 30, 2019, the Company recorded a liability of $2.4 million related to the estimated employment tax under-withholding for the years 2014 through 2018. By September 30, 2019, the liability totaled $1.8 million, after the Company paid $0.6 million to the IRS for these taxes and made an additional accrual covering the estimated under-withholding tax liability through 2019. In addition, at September 30, 2019 the Company recorded a receivable from the affiliated companies totaling $2.4 million. In October 2019, an amendment to the employment agreement was executed, giving the Company the contractual right of offset for any amounts owed to the Company, and giving the Company the right to withhold payments equal to amounts reasonably estimated to potentially become due to the Company by the affiliated companies from any amounts owed under the employment agreement. During the three months ended March 31, 2020, an additional accrual was recorded for $0.2 million related to potential penalties and interest on the IRS obligation. As of June 30, 2020, the receivable from Mr. Chisholm was $1.4 million, which is equal to the payable to the IRS and was netted with Mr. Chisholm’s severance liability. Both the IRS and severance liabilities are recorded in accrued liabilities on the consolidated balance sheet.

On January 5, 2020, Mr. Chisholm ceased to be an employee of the Company.

Note 21 — Revision of Prior Financial Statements

During preparation of June 30, 2020 financial statements, two additional errors impacting the prior financial statements were identified, as follows:


•	Currency Translation Adjustment and Other Comprehensive Income of $1.1 million was not recognized in earnings in connection with the dissolution of the Company’s wholly owned foreign entity, PetroValve International in 2015.


•	Cash flow presentation relating to proceeds received from the sale of FCC (which occurred in the first quarter of 2019) and subsequent release of escrow amounts in subsequent periods that were improperly classified between operating and investing activities.

Consolidated Balance Sheets - The revision relating to currency translation discussed above had no impact on total stockholders’ equity, but impacted the components of stockholders’ equity as follows (in thousands):



	As of December 31, 2018
	As previously reported			Revisions			As revised
Accumulated other comprehensive loss	$	(1,116	)	$	1,147		$	31
Retained earnings (accumulated deficit)	(107,176		)	(1,147		)	(108,323		)



	As of March 31, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(1,022	)	$	1,147		$	125
Retained earnings (accumulated deficit)	(76,314		)	(1,147		)	(77,461		)

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS



	As of June 30, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(998	)	$	1,147		$	149
Retained earnings (accumulated deficit)	(90,727		)	(1,147		)	(91,874		)



	As of September 30, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(962	)	$	1,147		$	185
Retained earnings (accumulated deficit)	(101,770		)	(1,147		)	(102,917		)



	As of December 31, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(966	)	$	1,147		$	181
Retained earnings (accumulated deficit)	(141,091		)	(1,147		)	(142,238		)



	As of March 31, 2020
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(1,089	)	$	1,147		$	58
Retained earnings (accumulated deficit)	(205,058		)	(1,147		)	(206,205		)

*As previously reported numbers reflect the revised balances for each of the periods as disclosed in the period ended March 31, 2020.

Consolidated Statements of Cash Flows - The revision discussed above impacted the statement of cash flow as follows (in thousands):



	For the three months ended March 31, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(18,661	)	$	14,219		$	(4,442	)
Other long-term assets	—			3,286			3,286
Net cash used in operating activities	(25,721		)	17,505			(8,216		)
Proceeds from sale of business	169,722			(17,505		)	152,217
Net cash provided by investing activities	169,290			(17,505		)	151,785

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS



	For the six months ended June 30, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(16,209	)	$	14,219		$	(1,990	)
Other long-term assets	—			3,286			3,286
Net cash used in operating activities	(23,849		)	17,505			(6,344		)
Proceeds from sale of business	169,722			(17,505		)	152,217
Net cash provided by investing activities	168,868			(17,505		)	151,363



	For the nine months ended September 30, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(14,974	)	$	10,938		$	(4,036	)
Other long-term assets	—			3,286			3,286
Net cash used in operating activities	(14,348		)	14,224			(124		)
Proceeds from sale of business	169,722			(14,224		)	155,498
Net cash provided by investing activities	167,497			(14,224		)	153,273



	For the year ended December 31, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(8,359	)	$	10,938		$	2,579
Other long-term assets	1,131			3,286			4,417
Net cash used in operating activities	(18,769		)	14,224			(4,545		)
Proceeds from sale of business	169,722			(14,224		)	155,498
Net cash provided by investing activities	166,937			(14,224		)	152,713



	For the three months ended March 31, 2020
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	6,926		$	(3,281	)	$	3,645
Net cash used in operating activities	(20,496		)	(3,281		)	(23,777		)
Proceeds from sale of business	—			3,281			3,281
Net cash provided by investing activities	41			3,281			3,322

In our March 31, 2020 financial statements, we disclosed the correction of two immaterial errors relating to intangibles that should have been written off in prior periods and improper elimination of profit on intercompany inventory transactions. Such revisions were not material to the previously issued financial statements.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Management evaluated the impact of these errors, individually and in the aggregate, on previously issued financial statements and concluded the impact was not material. Due to the currency translation error, net loss for the year ended December 31, 2015 was originally reported as $13.5 million and would be revised to $14.6 million.

FLOTEK INDUSTRIES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 22 — Subsequent Events

In April 2020, the Company was notified by the NYSE that the average closing stock price had fallen below the continued listing standard of a share price of $1.00 (measured over a 30 day trading average). The Company had until October 2020 (later extended to December 2020) to cure the deficiency. On July 1, 2020, the Company was notified by the NYSE that the deficiency had been cured, and the noncompliance indicator was removed from the Company’s common shares.

On July 28, 2020, the Company received a $6.3 million tax refund, including $0.2 million of interest, pursuant to the CARES Act that extended NOL carryback provisions related to the filing of Form 1139 requesting a refund as a result of an analysis related to the extended NOL carryback provision.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Quarterly Report on Form 10-Q (“Quarterly Report”), and in particular, Part I, Item 2 — “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains “forward-looking statements” within the meaning of the safe harbor provisions, 15 U.S.C. § 78u-5, of the Private Securities Litigation Reform Act of 1995 (“Reform Act”). Forward-looking statements are not historical facts, but instead represent Flotek Industries, Inc.’s (“Flotek” or “Company”) current assumptions and beliefs regarding future events, many of which, by their nature, are inherently uncertain and outside the Company’s control. Such statements include estimates, projections, and statements related to the Company’s business plan, objectives, expected operating results, and assumptions upon which those statements are based. The forward-looking statements contained in this Quarterly Report are based on information available as of the date of this Quarterly Report.

The forward-looking statements relate to future industry trends and economic conditions, forecast performance or results of current and future initiatives and the outcome of contingencies and other uncertainties that may have a significant impact on the Company’s business, future operating results and liquidity. These forward-looking statements generally are identified by words including, but not limited to, “anticipate,” “believe,” “estimate,” “continue,” “intend,” “expect,” “plan,” “forecast,” “project,” and similar expressions, or future-tense or conditional constructions such as “will,” “may,” “should,” “could,” etc. The Company cautions that these statements are merely predictions and are not to be considered guarantees of future performance. Forward-looking statements are based upon current expectations and assumptions that are subject to risks and uncertainties that can cause actual results to differ materially from those projected, anticipated, or implied.

A detailed discussion of potential risks and uncertainties that could cause actual results and events to differ materially from forward-looking statements is included in Part I, Item 1A — “Risk Factors” of the Annual Report on Form 10-K for the year ended December 31, 2019, as amended (“Annual Report”) and periodically in subsequent reports filed with the Securities and Exchange Commission (“SEC”). The Company has no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events, except as required by law.

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with the unaudited condensed consolidated financial statements and the related notes thereto of this Quarterly Report, as well as the Annual Report. Phrases such as “Company,” “we,” “our,” and “us” refer to Flotek Industries, Inc. and its subsidiaries.

Executive Summary

Flotek is a technology-driven global chemistry and data company that develops and supplies engineered chemistry solutions, equipment, data and analytical services to industrial, commercial and consumer markets. The Company continued its reinvention, which began in the first quarter of 2020 by reducing expenses, scrutinizing capital spending to ensure alignment to near-term revenue, acquiring JP3 to secure a footprint in the emerging data analytics market, and aggressively launching a sustainable line of sanitizer and disinfectant products built on its expertise in high-quality, specialized chemistry technologies.

Continuing Operations

With the acquisition of JP3 in May 2020, the Company now has two operating segments: Chemistry Technologies and Data Analytics, which are both supported by its continuing Research & Innovation advanced laboratory capabilities.

Chemistry Technologies

The Company’s Chemistry Technologies segment includes specialty chemistries, logistics and technology services. The Company designs, develops, manufactures, packages, distributes, delivers, and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in oil and gas well drilling, cementing, completion, remediation, and stimulation activities designed to maximize recovery in both new and mature fields. Customers of this product line of the Chemistry Technologies business segment include major integrated oil and gas companies, oilfield services companies, independent oil and gas companies, pressure-pumping service companies, national and state-owned oil companies, and international supply chain management companies.

In the second quarter of 2020, the Company launched a line of sanitizers and disinfectants for commercial and personal consumer use. These products build on the Company’s historical expertise in chemistry and leverage its infrastructure, personnel, competencies, supply chain, research, and historic consumer market experiences yielding a competitive product offering in this rapidly growing segment. Given the increase in global demand for sanitizer products due to COVID-19, the Company's concentration of customers is shifting and diversifying, which helps to reduce credit and business risk.

Data Analytics

The Company’s Data Analytics segment, created in conjunction with the acquisition of JP3, includes the design, development, production, sale and support of equipment and services that create and provide valuable information about the composition of its energy customers’ hydrocarbon streams. JP3 is continuing its transition to a Data-as-a-Service (DaaS) subscription model of selling data generated by its line of Verax analyzers, deployed remotely “at the edge” across the oil and gas sector, and software services via its cloud-based Viper software platform.

JP3 creates and sells data systems and analytics services into the oil and gas market. The Company sells equipment with a software license and (DaaS) subscriptions. The data is provided in real time, every fifteen seconds, at the point-of-use and via the cloud, to end use customers. This composition and physical properties information increases efficiency and decreases operating costs for producers, midstream operators, refiners and distribution companies.

The customers of JP3 span across the entire market, from production upstream to midstream facilities to refineries and distribution networks. To date, JP3 has focused sales solely on North American markets. The Data Analytics segment provides real-time hydrocarbon composition data that helps its customers generate additional profit by enhancing blending, increasing efficiencies of towers, enabling automation and robotization of fluid handling, and reducing losses due to give-away.

Research & Innovation

Flotek Research and Innovation supports both segments through formulations, technical support, basin & reservoir studies, data analytics, and new technology projects. The purpose of the organization is to supply the segments with enhanced products and services that generate current and future revenues, while advising company management on opportunities concerning technology, environmental, and industry trends. The Research and Innovation facilities support advances in chemistry performance, detection, optimization, and manufacturing.

Discontinued Operations

As previously disclosed, the Company sold Florida Chemical Company, LLC (“FCC”) effective as of February 28, 2019. As a result, the Company’s CICT segment was classified as discontinued operations. Financial results for the first three and six months of 2019 include results from the Company’s CICT segment during that time period.

Outlook on Economic Conditions

During the first and second quarters of 2020, the oil and gas markets experienced significant impacts from both the supply and the demand side. On the demand side, the COVID-19 pandemic resulted in a drop in economic activity and a corresponding destruction of global demand for oil, gas and associated products. On the supply side, pricing and production wars between key oil-producing countries led to global oversupply.

The demand destruction and oversupply together caused unprecedented disruption to all sectors of the oil and gas markets. Prices for crude oil fell from over $60/bbl. in January 2020 to nearly $20/bbl. by May 2020, with futures turning negative for a brief period in April 2020. Oil and gas operators announced budget cuts of more than 40%, or $42 billion year-over-year, according to RS Energy Group, and announced shut-ins of more than 1.4 million barrels of production. The North American rig count declined approximately 70% from January 2020 to the end of June 2020, based on the Baker Hughes rig count figures, reflecting disproportionate impact to domestic markets.

Midstream and downstream markets were affected as well, as domestic gasoline demand fell by approximately 45% in April 2020 (almost 5 million barrels per day) and refinery utilization dropped below 70%. The Company expects negative impacts to all facets of the oil and gas markets to continue for an extended period before returning to pre-crash levels. Any further material COVID-19 disruption or significant setback in oil demand arising from a slower economic recovery could present downside risks to this outlook.

Conversely, the COVID-19 pandemic has created increased demand for certain specialty chemicals, and in particular disinfectants and sanitizers. The increased usage globally of personal protection equipment has expanded beyond masks, face shields, and gloves to include both disinfectants and sanitizers. With the outbreak of COVID-19, sales of hand sanitizers and disinfectants has swelled

across every region in the world, which led to a global shortage. Consequently, the market has experienced shortages of key raw materials used to make these products, including USP-grade alcohol, woven cellulosics for wipes, and various active ingredients. This rapid growth is accompanied by a need for sustained higher volumes of sanitizing products as COVID-19 is expected to have a long-term impact on social awareness, personal hygiene habits and consumer and commercial cleaning protocols.

Company Outlook

In response to the deteriorating market conditions and anticipating ongoing volatility, Flotek has reduced its cost structure to meet anticipated market activity and reduce the Company’s break-even levels. Among other cost-cutting initiatives:


•	The Company’s CEO, John W. Gibson, Jr., reduced his base salary by 20%, and each of the other executive officers reduced his or her salary by 10%, through December 31, 2020 in exchange for restricted stock, effective as of April 1, 2020.


•	The board of directors of Flotek approved a 20% reduction in the fees to be paid to the directors, effective as of April 1, 2020.


•	The Company consolidated office space by moving all employees at its corporate headquarters into its GRIC facility and buying out the remaining term of the corporate headquarters lease for a significant discount, with the move completed by the end of June 2020.


•	The Company reduced headcount by 35% on March 30, 2020.


•	The Company decreased discretionary spending across all business operations.

These efforts were in addition to the previously-announced restructuring of the Company’s terpene supply agreement in February of 2020, which more closely matched the Company’s ongoing obligations for terpene with expected need, and bringing more legal work in-house to reduce outside legal expenses.

Flotek has also focused on ongoing needs of customers and the market to diversify its business and accelerate growth through deployment of capital, with an emphasis on digital transformation in the oil and gas markets. On May 18, 2020, the Company closed the acquisition of all the ownership interests of JP3, which gives Flotek access to the midstream and downstream markets and diversifies exposure to volatility in the upstream sector. As Flotek’s newly-created Data Analytics segment, JP3 is positioned for growth both domestically and internationally. In addition to increasing market share, the Data Analytics segment is pursuing product enhancements that enable growth opportunities with current and prospective customers.

The Company’s Chemistry Technologies segment has focused on development of competitively-priced product lines that are responsive to current market including wellbore protection and damage mitigation products as the domestic market has shifted to shutting in wells. In response to a forecasted reduction in capital available to customers for drilling with a shift to optimizing existing infrastructure, the Company initiated several efforts to use specialty chemicals to improve enhanced oil recovery (EOR). The Company has also leveraged its international footprint in the Middle East to include unconventional, conventional, and enhanced oil recovery programs.

The Chemistry Technologies segment has also used its expertise in specialty chemistry, existing chemistry infrastructure and facilities, and historical consumer market experience to launch a product line of sanitizers and disinfectants, as discussed above. The Company believes the new sanitizer and disinfectant products slot into the premium market and will be competitive over the long-term.

The Company has also made changes to its executive team to align with its growth focus. TengBeng Koid, an experienced energy executive with significant upstream, midstream, downstream and digital experience, joined Flotek as President of Global Business in June 2020 and oversees all domestic and international sales and business development efforts for both the Chemistry Technologies and the Data Analytics segments. Additionally, Michael E. Borton joined the Company as Chief Financial Officer in August 2020, bringing 35 years of experience serving in financial and operational leadership roles for high-growth, Software as a Service (SaaS)

technology companies in a wide range of industries. Finally, Ryan Ezell, Ph.D, has been promoted to the role of President of Chemistry Technologies from Senior Vice President of Operations at Flotek.

Consolidated Results of Operations (in thousands):



	Three months ended June 30,						Six months ended June 30,
	2020			2019			2020			2019
Revenue	$	8,880		$	34,692		$	28,296		$	77,949
Operating expenses (excluding depreciation and amortization)	11,632			38,121			34,473			82,089
Operating expenses %	131.0		%	109.9		%	121.8		%	105.3		%
Corporate general and administrative	5,395			6,054			9,888			13,335
Corporate general and administrative %	60.8		%	17.5		%	34.9		%	17.1		%
Depreciation and amortization	468			2,119			2,659			4,379
Research and development costs	1,638			2,076			4,193			4,360
(Gain) loss on disposal of long-lived assets	(22		)	(4		)	(55		)	1,093
Impairment of fixed assets and long-lived assets	—			—			57,454			—
Loss from operations	(10,231		)	(13,674		)	(80,316		)	(27,307		)
Operating margin %	(115.2		)%	(39.4		)%	(283.8		)%	(35.0		)%
Gain on lease termination	576			—			576			—
Interest and other income (expense), net	62			677			11			(1,213		)
Loss before income taxes	(9,593		)	(12,997		)	(79,729		)	(28,520		)
Income tax benefit	32			192			6,201			503
Loss from continuing operations	(9,561		)	(12,805		)	(73,528		)	(28,017		)
(Loss) income from discontinued operations, net of tax	—			(1,608		)	—			44,466
Net (loss) income	$	(9,561	)	$	(14,413	)	$	(73,528	)	$	16,449
Net (loss) income %	(107.7		)%	(36.9		)%	(259.9		)%	(35.9		)%

Consolidated Results of Operations: Three and Six Months Ended June 30, 2020, Compared to the Three and Six Months Ended June 30, 2019

Consolidated revenue for the three and six months ended June 30, 2020, decreased $25.8 million, or 74.4%, and $49.7 million or 63.7%, respectively, and versus the same periods of 2019. The decrease in revenue was largely a result of the continued volatile macro-environment for U.S. onshore drilling and completion activity, impacted by political and economic events in foreign markets. In addition, concerns related to the COVID-19 virus impacted productivity and customers demand for products.

Consolidated operating expenses (excluding depreciation and amortization) for the three and six months ended June 30, 2020, decreased $26.5 million, or 69.5%, and $48 million or 58.0%, respectively, versus the same periods of 2019, and, as a percentage of revenue, increased by 21.1%, and 16.5%, respectively for the three and six months ended June 30, 2020. The decrease in operating expenses is primarily due to the lower cost of sales as a result of reduced revenues and lower freight, personnel, and travel and entertainment expenses.

Corporate general and administrative (“CG&A”) expenses are not directly attributable to products sold or services provided. CG&A costs for the three and six months ended June 30, 2020, decreased $0.7 million, or 10.9%, and $3.4 million or 25.8%, respectively, versus the same period of 2019. As a percentage of revenue, CG&A increased 43.3% and 17.8% for the three and six months ended June 30, 2020. The decrease in CG&A costs were primarily due to lower personnel costs, lower software licensing fees, lower stock based compensation and lower professional fees.

Depreciation and amortization expense decreased $1.7 million, or 77.9%, and $1.7 million, or 39.3%, for the three and six months ended June 30, 2020, respectively, and versus the same periods of 2019 primarily due to impairment of fixed and long-lived assets recorded in the first quarter 2020.

Research and development costs decreased $0.4 million, or 21.1%, and $0.2 million, or 3.8%, for the three and six months ended June 30, 2020, respectively, and versus the same periods of 2019 due to lower personnel costs as a result of reduction in force in the first quarter 2020.

Gain on disposal of long-lived assets had no change and increased $1.1 million, or 105.0% for the three and six months ended June 30, 2020, respectively, and versus the same periods of 2019.

Impairment of fixed asset and long-lived assets was $57.5 million due to a write-down of fixed assets, operating right-of-use (“ROU”) assets and intangible assets to estimated fair market value and recorded in the first quarter of 2020.

Loss from operations decreased $3.4 million, or 25.2%, and increased $53.0 million, or 194.1% and for the three and six months ended June 30, 2020, respectively, and versus the same period in 2019. The change in loss is primarily the result of the impairment charges, lower margins, lower sales volumes and lower plant utilization.

Interest and other income (expense), net increased $0.6 million, or 90.8%, and decreased $1.2 million, or 100.9% for the three and six months ended June 30, 2020, respectively, and versus the same period of 2019, primarily due to the termination of the Amended and Restated Revolving Credit, Term Loan and Security Agreement (as amended, the “Credit Facility”) with PNC Bank in the first quarter 2019.

The Company recorded an income tax benefit of $6.2 million, primarily as a result of the extended net operating loss carryback provisions included in the CARES Act, yielding an effective tax benefit rate of 0.3%, and 7.7%, for the three and six months ended June 30, 2020, respectively, compared to an income tax benefit of $0.5 million, yielding an effective tax benefit rate of 1.6% and and 3.3% for the comparable periods in 2019.

Results by Segment (in thousands):

Chemistry Technologies



	Three months ended June 30,					Six months ended June 30,
	2020		2019			2020			2019
Revenue	7,962		$	34,692		$	27,378		$	77,949
Gross margin	1,301		18,180			2,539			54,609
Gross margin %	16.3	%	52.4		%	9.3		%	70.1		%
Income from operations	(3,596	)	(7,651		)	(66,257		)	(12,984		)
Income from operations %	(45.2	)%	(22.1		)%	(242.0		)%	(16.7		)%

Chemistry Technologies Results of Operations: Three and Six Months Ended June 30, 2020, Compared to the Three and Six Months Ended June 30, 2019

Chemistry Technologies revenue for the three and six months ended June 30, 2020 decreased $26.7 million or 77.0%, and $50.6 million or 64.9%, respectively, versus the same period of 2019. The decrease in revenue during the second quarter of 2020 and the majority of the first half of 2020 was significantly driven by impacts from both the supply and the demand side. The COVID-19 pandemic resulted in a sharp decline in economic activity and a corresponding destruction of global demand for oil and gas, while pricing and production wars between key oil-producing countries led to global oversupply. The demand destruction and oversupply together caused unprecedented disruption to all sectors of the oil and gas markets, with a significant reduction in North American drilling and completion activity and its need for chemicals. While experiencing pricing and overall market compression in the oil and gas sector of the Chemistry Technologies segment, growth in the sanitizer and disinfectant sector evolved as a natural fit with the Company’s core technical and manufacturing capabilities, with potential positive long-term opportunity for diversification and sustainability of the portfolio, representing revenue for the Company in the second quarter of 2020.

Chemistry Technologies gross margin (excluding depreciation and amortization) for the three and six months ended June 30, 2020, decreased $16.9 million, or 92.8%, and $52.1 million or 95.4%, respectively versus the same period of 2019, and as a percentage of revenue, decreased 36.1%, and 60.8% for the three and six months ended June 30, 2020. Gross margins were influenced by shifts in completion technologies to more cost efficient and simplified chemistry and engineering packages, as well as continued pressure on market pricing to maintain key accounts and available market share. Subsequently, the Company executed on a number of activities to reduce cost of sales, freight, personnel, and its operational cost structure to minimize the impacts of revenue declines and modified product mix.

Chemistry Technologies income from operations (excluding depreciation and amortization) for the three and six months ended June 30, 2020, improved $4.1 million, or 53.0%, and decreased $53.3 million or 410.3%, respectively versus the same period of 2019, and as a percentage of revenue, decreased 23.1%, and 225.4% for the three and six months ended June 30, 2020. The increase in loss during the six months ended June 20, 2020 is primarily the result of the impairment charges of $57.5 million and lower margins due to sales volumes and plant utilization recorded in the first quarter of 2020.

Data Analytics



	May 18 - June 30
	2020
Revenue	$	918
Gross margin	370
Gross margin %	40.3		%
Income from operations	(1,151		)
Income from operations %	(125.4		)%

Data Analytics Results of Operations: May 18, 2020 to June 30, 2020

During the second quarter of 2020, the Company announced the purchase of JP3, an equipment and data company that automates real-time data and analytics to the energy industry to maximize the value of their hydrocarbons.

During the second quarter, revenue was hindered by sluggish-to-nonexistent capital spending across the entire oil and gas market. The second quarter came with site lockdowns and extreme caution to prevent the spread of COVID-19. The segment finished the quarter with $0.9 million of revenue that came from existing JP3 customers.

Off-Balance Sheet Arrangements

There have been no transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as “structured finance” or “special purpose entities” (“SPEs”), established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of June 30, 2020, the Company was not involved in any unconsolidated SPEs.

The Company has not made any guarantees to customers or vendors nor does the Company have any off-balance sheet arrangements or commitments that have, or are reasonably likely to have, a current or future effect on the Company’s financial condition, change in financial condition, revenue, expenses, results of operations, liquidity, capital expenditures, or capital resources that would be material to investors other than the long term terpene agreement discussed in Note 3 in Part I, Item I - Financial Statements of this Quarterly Report.

Critical Accounting Policies and Estimates

The Company’s Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Preparation of these statements requires management to make judgments, estimates, and assumptions that affect the amounts reported in the financial statements and accompanying footnotes. Part II, Item 8 — Financial Statements and Supplementary Data, Note 2 of “Notes to Consolidated Financial Statements” and Part II, Item 7 — Management’s Discussion and Analysis of Financial Condition and Results of Operations, “Critical Accounting Policies and Estimates” of the Company’s Annual Report, and the “Notes to Unaudited Condensed Consolidated Financial Statements” of this Quarterly Report describe the significant accounting policies and critical accounting estimates used to prepare the consolidated financial statements. Critical accounting policies and estimates are defined as those that are both most important to the portrayal of the Company’s financial condition and results of operations and require management’s most subjective judgments. The Company regularly reviews and challenges judgments, assumptions, and estimates related to critical accounting policies. The Company’s estimates and assumptions are based on historical experience and expected changes in the business environment; however, actual results may materially differ from the estimates. There have been no significant changes in the Company’s critical accounting policies and estimates during the six months ended June 30, 2020. However, during the six months ended June 30, 2020, the Company evaluated and recorded remeasurement and impairment charges on right of use assets and fixed assets, respectively. Secondly, during the six months ended June 30, 2020, the Company acquired JP3 and recorded the fair value of net assets acquired as of the closing date of May 18, 2020.

Recent Accounting Pronouncements

Recent accounting pronouncements which may impact the Company are described in Note 2 — “Recent Accounting Pronouncements” in Part I, Item 1 — “Financial Statements” of this Quarterly Report.

Capital Resources and Liquidity

Overview

The Company’s ongoing capital requirements relate to the Company's need to to acquire and maintain equipment, fund working capital requirements, and when the opportunities arise, to make strategic acquisitions and repurchase Company stock. During the first six months of 2020, the Company funded capital requirements primarily with cash from operations and cash on hand, including proceeds from the sale of the CICT segment, received on March 1, 2019.

Historically, the Company’s primary source of debt financing was its $75 million Credit Facility with PNC Bank. Upon closing of the sale of the CICT segment, on March 1, 2019, the Company repaid the outstanding balance, interest, and fees related to the revolving credit facility, and subsequently terminated the Credit Facility.

As of June 30, 2020, the Company had available cash and cash equivalents of $59.9 million. For the remainder of 2020, the Company expects capital spending of approximately $2.0 million to $3.0 million for the Company’s Chemistry segment and $1.0 million to $2.0 million for the Company’s Data Analytics segment. The Company expects to fund operations and capital expenditures with internal cash on hand, including the PPP loan funded in April 2020 for $4.8 million to Flotek and $0.9 million to JP3, the tax refund of $6.1 million, and the release of $6.6 million from the indemnity escrow established pursuant to the sale of FCC to ADM effective February 28, 2019.

Any excess cash generated may be used for outside growth opportunities or retained for future use.

Cash Flows

Consolidated cash flows by type of activity are noted below (in thousands):



	Six months ended June 30,
	2020			2019
Net cash used in operating activities	$	(29,216	)	$	(6,344	)
Net cash (used in) provided by investing activities	(16,424		)	151,363
Net cash provided by (used in) financing activities	5,023			(49,911		)
Net cash provided by discontinued operations	—			16
Effect of changes in exchange rates on cash and cash equivalents	(31		)	2
Net (decrease) increase in cash and cash equivalents and restricted cash	$	(40,648	)	$	95,126

Operating Activities

Net cash used in operating activities was $29.2 million and $6.3 million during the six months ended June 30, 2020 and 2019, respectively. Consolidated net loss for the six months ended June 30, 2020 and 2019, totaled $73.5 million and $28.0 million, respectively. The cash used in operating activities is primarily due to two one-time payments, one to FCC to amend the Company’s long-term terpene supply agreement and one to ADM related to the final post-closing working capital adjustment related to the sale of the CICT segment in 2019.

During the six months ended June 30, 2020, non-cash adjustments to net income totaled $62.1 million. Contributory non-cash items consisted primarily of a $57.5 million impairment charge consisting of $30.2 million impairment on fixed assets, $15.2 million on impairment of intangibles, and$7.4 million impairment on ROU assets. Additional non-cash charges included $2.7 million for depreciation and amortization, $0.5 million for allowance for doubtful accounts, $1.5 million for stock compensation expense, and $0.5 million for provision for excess and obsolete inventory.

During the six months ended June 30, 2019, non-cash adjustments to net income totaled $27.0 million. Contributory non-cash items consisted primarily of $17.9 million for changes to deferred income taxes driven by the valuation allowance recorded against deferred tax assets, $4.4 million for depreciation and amortization, $1.1 million on loss of disposal of assets,$0.5 million non-cash lease expense, and $1.7 million for stock compensation expense.

During the six months ended June 30, 2020, changes in working capital used $17.8 million in cash, primarily resulting from a decrease in accrued liabilities and accounts payable of $27.3 million, increase in accounts receivable, inventories and other current assets of $25.2 million, offset by an increase in income tax payable of $0.1 million and reducing income tax receivable by $6.3 million.

During the six months ended June 30, 2019, changes in working capital used $5.3 million in cash, primarily resulting from a decrease in accrued liabilities and accounts payable of $14.4 million, increase in accounts receivable and inventories of $7.2 million partially offset by an increase in income tax payable of $1.2 million, and reducing income tax receivable , other current assets and restricted cash by $17.2 million.

Investing Activities

Net cash used in investing activities was $16.4 million for the six months ended June 30, 2020. The cash used in investing activities is primarily due to the acquisition of JP3 during the second quarter 2020.

Net cash provided by investing activities was $151.4 million for the six months ended June 30, 2019. Cash provided by investing activities primarily included $152.2 million of proceeds from sale of business and $0.1 million of proceeds received from the sale of assets, partially offset by $0.8 million for capital expenditures and $0.2 million for the purchase of various patents.

Financing Activities

Net cash generated through financing activities was $5.0 million for the six months ended June 30, 2020. Cash generated through financing activities primarily included $4.8 million proceeds from borrowings under the PPP, and $0.4 million proceeds from the sale of common stock partially offset by $0.1 million cash used in the purchase of treasury stock.

Net cash used in financing activities was $49.9 million for the six months ended June 30, 2019, primarily due to using $92.7 million for repayments of debt, offset by borrowings on revolving credit facility of $42.9 million.

Contractual Obligations

Cash flows from operations are dependent on a variety of factors, including fluctuations in operating results, accounts receivable collections, inventory management, and the timing of payments for goods and services. Correspondingly, the impact of contractual obligations on the Company’s liquidity and capital resources in future periods is analyzed in conjunction with such factors.

Material contractual obligations consist of payments of finance and operating lease obligations. Contractual obligations at June 30, 2020, are as follows (in thousands):



	Payments Due by Period
	Total		Less than 1 year		1 - 3 years		3 - 5 years		More than 5 years
Finance lease obligations	$	213	$	70	$	101	$	42	$	—
Operating lease obligations	13,969		1,371		2,593		2,684		7,321
Supply commitments for raw materials	17,724		1,974		15,750		—		—
Total	$	32,390	$	3,899	$	18,444	$	2,726	$	7,321

Item 3. Quantitative and Qualitative Disclosures About Market Risk

The Company is exposed to market risk from changes in interest rates, commodity prices, and foreign currency exchange rates. There have been no material changes to the quantitative or qualitative disclosures about market risk set forth in Part II, Item 7A of the Company’s Annual Report.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. The Company’s disclosure controls and procedures are also designed to ensure such information is accumulated and communicated to management, including the principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosures. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance that control objectives are attained.

The Company previously identified material weaknesses in its internal control over financial reporting relating to the ineffective design and operating effectiveness of internal controls over the elimination of intercompany profits in inventory, the recording of certain intangible assets and the operating effectiveness of controls relating to impairment analyses of fixed and long-lived assets.

In addition to the material weaknesses mentioned above, during the preparation of the financial statements for the quarter ended June 30, 2020 the Company identified an error relating to the classification of cash flows from the Florida Chemical Company sale in 2019. Specifically, errors were identified relating to the classification of proceeds from the sale and treatment of funds released from escrow subsequent to the sale. Based on these evaluations, the Company has identified the material weaknesses in internal control of financial reporting relating to ineffective design and operation of controls over nonrecurring transactions, including derecognition of items and cash flow presentation relating to disposal transactions, ineffective design and operation of

controls over the elimination of intercompany profits in inventory, and operating ineffectiveness of controls relating to impairment evaluations.

The Company believes that, notwithstanding the material weaknesses mentioned above, the consolidated financial statements contained in this Form 10-Q and its previously issued financial statements, present fairly in all material respects, the consolidated financial positions, results of operations and cash flows of the Company and its subsidiaries in conformity with generally accepted accounting principles in the United States as of the dates and for the periods stated therein.

The Company’s management, including its principal executive officer and principal financial officer, have evaluated the effectiveness of the Company’s disclosure controls and procedures, as required by Rule 13a-15(e) and 15d-15(c) of the Exchange Act as of June 30, 2020 and has concluded that the Company’s disclosure controls and procedures were not effective as of June 30, 2020 due to the material weaknesses in internal control over financial reporting described above.

Remediation Plan

As of June 30, 2020, the material weaknesses discussed above have not been remediated. The Company implemented certain remediation action and continues to test and evaluate the elements of the remediation plan.

These elements include:


•	Implementing monitoring controls over the review and validation of intangible assets


•	Expanding monthly close and consolidation procedures


•	Modifying the chart of accounts


•	Expanded monthly management review controls


•	Expanding controls over impairments of long-lived assets

Changes in Internal Control Over Financial Reporting

Except for the remediation actions discussed above, there have been no changes in the Company’s system of internal control over financial reporting during the three months ended June 30, 2020, that have materially affected, or are reasonably likely to materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

Litigation

Item 1A. Risk Factors

The following risk factor supplements the “Risk Factors” section in Part 1, Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed on March 16, 2020:

The COVID-19 pandemic has significantly reduced demand for our services and may have a material adverse impact on our financial condition, results of operations and cash flows.

The effects of the COVID-19 (coronavirus) pandemic, including actions taken by businesses and governments, have resulted in a significant and swift reduction in international and U.S. economic activity. These effects have materially and adversely affected, and may continue to materially and adversely affect, the demand for oil and natural gas, as well as for our services and products. The decline in our customers’ demand for our services and products is likely to have a material adverse impact on our financial condition, results of operations and cash flows. In addition, we have adopted social distancing and work-from-home procedures, which have had and may continue to have an impact on the ability of employees and management of the Company to communicate and work efficiently.

While the full impact of the COVID-19 outbreak is not yet known, we are closely monitoring the effects of the pandemic on commodity demands and on our customers, as well as on our operations and employees. Any future development and effects will be highly uncertain and cannot be predicted, including the scope and duration of the pandemic; further adverse revenue, accounts receivable aging and collections, and net income effects; disruptions to our operations; third party providers’ ability to support our operations; customer shutdowns of oil and gas exploration and production; the effectiveness of our work from home arrangements; employee impacts from illness, school closures and other community response measures; any actions taken by governmental authorities and other third parties in response to the pandemic; and temporary closures of our facilities or the facilities of our customers and suppliers. The uncertain future development of this crisis could materially and adversely affect our business, operations, operating results, financial condition, liquidity or capital levels.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Issuer Purchases of Equity Securities

The Company’s stock compensation plans allow employees to elect to have shares withheld to satisfy their tax liabilities related to non-qualified stock options exercised or restricted stock vested or to pay the exercise price of the options. When this settlement method is elected by the employee, the Company repurchases the shares withheld upon vesting of the award stock.

On June 9, 2020, the board of directors of the Company rescinded the authorization to repurchase the Company’s stock that had been previously approved in June 2015.

Repurchases of the Company’s equity securities during the three months ended June 30, 2020 that the Company made or were made on behalf of the Company or any “affiliated purchaser,” as defined in Rule 10b-18(a)(3) under the Exchange Act are as follows:



Period	Total Number of Shares Purchased ⁽¹⁾	Average Price Paid per Share
April 1, 2020 to April 30, 2020	562	$	0.81
May 1, 2020 to May 31, 2020	40,040	$	0.99
June 1, 2020 to June 30, 2020	1,779	$	1.02
Total	42,381


(1)	The Company purchases shares of its common stock (a) to satisfy tax withholding requirements and payment remittance obligations related to period vesting of restricted shares and exercise of non-qualified stock options, (b) to satisfy payments required for common stock upon the exercise of stock options, and (c) as part of a publicly announced repurchase program on the open market.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits



Exhibit Number		Description of Exhibit
2.1		Share Purchase Agreement, dated as of January 10, 2019, by and between the Company and ADM (portions of this exhibit have been omitted pursuant to a confidential treatment request, which has been granted) (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed on March 4, 2019).¹
2.2		Membership Interest Purchase Agreement, dated as of May 18, 2020, by and between the Company, JP3 Measurement, LLC, the Sellers party thereto, and John A. Cardwell, as Seller Representative) (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed on May 19, 2020).¹
3.1		Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Form 10-Q for the quarter ended September 30, 2007).
3.2		Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Form 10-Q for the quarter ended September 30, 2009).
3.3		Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Flotek Industries, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on May 7, 2020).
3.4		Second Amended and Restated Bylaws, dated October 11, 2017 (incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on October 17, 2017).
4.1		Form of Certificate of Common Stock (incorporated by reference to Appendix E to the Company’s Definitive Proxy Statement filed on September 27, 2001).
10.1		Promissory Note dated April 16, 2020 in favor of PNC Bank, National Association (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on March 3,April 17, 2020). ¹
10.2		Employment Agreement, dated May 18, 2020, between the Company and Matthew R. Thomas (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on May 19, 2020).
10.3		Employment Agreement, dated June 4, 2020, between the Company and TengBeng Koid (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on June 22, 2020).
10.4	*	Separation and Release Agreement, dated July 28, 2020, between the Company and Elizabeth Wilkinson
31.1	*	Rule 13a-14(a) Certification of Principal Executive Officer.
31.2	*	Rule 13a-14(a) Certification of Principal Financial Officer.
32.1	**	Section 1350 Certification of Principal Executive Officer.
32.2	**	Section 1350 Certification of Principal Financial Officer.
101.INS	*	XBRL Instance Document.
101.SCH	*	XBRL Schema Document.
101.CAL	*	XBRL Calculation Linkbase Document.
101.LAB	*	XBRL Label Linkbase Document.
101.PRE	*	XBRL Presentation Linkbase Document.
101.DEF	*	XBRL Definition Linkbase Document.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
*		Filed herewith.
**		This certification is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.
1		Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company undertakes to furnish supplemental copies of any of the omitted schedules upon request by the SEC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



FLOTEK INDUSTRIES, INC.

By:		/s/ JOHN W. GIBSON, JR.
		John W. Gibson, Jr.
		President, Chief Executive Officer and
		Chairman of the Board

Date:		August 17, 2020



FLOTEK INDUSTRIES, INC.

By:		/s/ Michael Borton
		Chief Financial Officer


Date:		August 17, 2020

Exhibit

Rev. 7/10/2019

SEPARATION AND RELEASE AGREEMENT

This Separation and Release Agreement (“Agreement”) is entered into as of the Effective Date (as hereinafter defined) by and between Elizabeth Wilkinson (“Wilkinson”), an individual, and Flotek Industries, Inc., a Delaware corporation (the “Company”).

WHEREAS, Wilkinson is a former employee of the Company; and

WHEREAS, Wilkinson and the Company have concluded that it is in their mutual best interests to separate from the employment relationship;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby expressly acknowledged, the undersigned parties agree as follows:

1.Date of Separation.

(a) Effective as of June 15, 2020 (the “Separation Date”), Wilkinson shall be separated from her employment by the Company and from the position held by Wilkinson with respect to the Company. This Agreement shall become effective, however, on the “Effective Date,” as defined in subsection (b) below.

(b) Wilkinson understands that she has 45 days from June 15, 2020 (the “Submittal Date”), which is the date a copy of this Agreement was received by her, to review and consider this Agreement and to decide whether to agree to and execute this Agreement. Wilkinson understands that, while it is her right to decide to enter into and execute this Agreement before the end of this 45-day period that she is under no obligation to do so. If Wilkinson signs and returns this Agreement before the end of this 45-day period, it is because Wilkinson freely chose to do so after carefully considering its terms. Wilkinson is entitled to revoke her execution of this Agreement within 7 days of signing it, and this Agreement does not become effective or enforceable until the day after this 7-day revocation period has expired (the “Effective Date”). If the revocation period expires on a weekday or holiday, Wilkinson will have until the end of the next business day to revoke. Notwithstanding anything to the contrary set forth herein, neither Wilkinson nor the Company shall have any obligation hereunder until such 7-day revocation period has expired with such revocation right unexercised.

2.Compensation through Separation Date, Severance Payment and Benefits.

(a) Within six (6) business days after the Separation Date, the Company will pay Wilkinson a cash payment equal to the sum of (i) her regular salary through the Separation

Page 1 of 9

Rev. 7/10/2019

Date and (ii) her accrued but unused vacation benefits. Wilkinson understands that she is entitled to this payment regardless of whether she chooses to sign this Agreement.

(b) In exchange for the promises of Wilkinson contained in this Agreement and the release of claims as set forth in Section 4 of this Agreement, the Company will pay Wilkinson a total of $918,750 in severance pay in nine equal monthly payments payable at the end of each month with the first payment commencing the month following the Effective Date. Wilkinson agrees that the consideration the Company will provide includes amounts in addition to anything of value to which Wilkinson is already entitled.

(c) The following unvested shares of restricted stock shall be considered vested as of June 15, 2020 (i) 30,000 shares of common stock of the Company issued pursuant to the grant dated December 28, 2018 and (ii) 32,407 shares of common stock of the Company issued pursuant to the grant dated April 1, 2020.

(d) If Wilkinson timely and properly elects health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) the Company shall reimburse her for the monthly COBRA premium paid by Wilkinson for herself and her dependents who were covered immediately preceding the Separation Date. The reimbursement shall be paid to Wilkinson prior to the last day of the month immediately following the month in which the premium payment is remitted. Wilkinson is eligible to receive such reimbursement until the earliest of: (i) the 12-month anniversary of the Separation Date; (ii) the date Wilkinson (or her dependents, if applicable) is no longer eligible to receive COBRA continuation coverage and (iii) the date on which Wilkinson receives substantially similar coverage from another employer or other source.

(e) All payments to Wilkinson shall be subject to withholding of employment, FICA, and other taxes as required by law.

3.Equity Awards; Other Benefits. Wilkinson shall not be entitled to coverage under any employee benefit plan of the Company subsequent to the Separation Date except as set forth in Section 2(b), 2(c) and 2(d) of this Agreement. The terms of this Agreement shall not affect in any respect the rights of Wilkinson with respect to contributions previously made by or with respect to Wilkinson pursuant to the Section 401(k) Plan of the Company or any other vested rights under ERISA-covered employee benefit plans, which shall be governed by the terms of such plan(s), as applicable on the date Wilkinson signs this Agreement.

4.Release. In consideration for the Company’s promises in this Agreement, including the promise to pay compensation to Wilkinson in Section 2(b) of this Agreement, Wilkinson, on

Page 2 of 9

Rev. 7/10/2019

behalf of herself and her heirs, executors, administrators, successors, assigns, and any other person claiming by, through, or under her, voluntarily and knowingly waives, releases and discharges the Company, its subsidiaries and their direct and indirect affiliates, and their respective successors, assigns, divisions, representatives, agents, officers, directors, stockholders, and employees (the “Released Parties”), from any claims, demands and/or causes of action whatsoever, presently known or unknown, that are based upon facts occurring on or prior to the Effective Date, including but not limited to, the following: (a) any statutory claims under Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act of 1967, the Older Workers Benefits Protection Act of 1990, the Americans with Disabilities Act of 1990, the Civil Rights Acts of 1964 and 1991, the National Labor Relations Act, or other U.S. (federal, state or local) or international laws (all as amended), (b) any tort or contract claims, (c) any claims for options or rights to acquire stock or the issuance of or right to retain restricted stock, and/or (d) any claims, matters or actions related to Wilkinson employment and/or affiliation with, or separation from, the Company, and any facts or circumstances relating to the negotiation of this Agreement. Such release does not, however, reach the Company’s obligations under this Agreement. Nothing in this Agreement is intended to waive claims (i) for unemployment or workers’ compensation benefits, (ii) that may arise after Wilkinson signs this Agreement, or (iii) which cannot be released by private agreement. In addition, nothing in this Agreement (including but not limited to the release of claims, proprietary information, confidentiality, cooperation, and non-disparagement provisions) prevents Wilkinson from filing a charge or complaint with or from participating in an investigation or proceeding conducted by the EEOC, NLRB, the Securities and Exchange Commission (SEC), or any other any federal, state or local agency charged with the enforcement of any laws, or from exercising rights under Section 7 of the NLRA to engage in joint activity with other employees, although by signing this release Wilkinson is waiving rights to individual relief based on claims asserted in such a charge or complaint, or in any other proceeding brought by Wilkinson or asserted by any third-party on Wilkinson’s behalf, except Wilkinson may have a right to receive a payment from a government agency (and not the Company) for information provided to the government agency, and except where such a waiver of individual relief is otherwise prohibited.

5.No Assignment of Claims. The Company and Wilkinson each represents and warrants to the other that it or she has not made any assignment and will make no assignment of any of the claims which are purported to be released and discharged by this Agreement.

6.Return of Company Property. Wilkinson agrees that she has returned to the Company all of the Company’s property in her possession, custody, or control, including but not limited to all of the tangible and intangible property belonging to the Company and relating to her employment with the Company. Wilkinson further represents and warrants that she will not retain any copies, electronic or otherwise, of such property, including any electronic copies stored on Wilkinson’s personal: (i) computers; (ii) USB storage devices; (iii) email accounts; and (iv) cloud storage

Page 3 of 9

Rev. 7/10/2019

accounts. Notwithstanding the foregoing, it is accepted and agreed that Wilkinson may retain her company-issued laptop and docking station.

7.Additional Covenants.

(a) Wilkinson acknowledges (i) receipt of all compensation and benefits due through the Separation Date as a result of services performed for the Company with the receipt of a final paycheck; (ii) Wilkinson has reported to the Company any and all work-related injuries incurred during employment; (iii) the Company properly provided any leave of absence because of Wilkinson’s or a family member’s health condition and Wilkinson has not been subjected to any improper treatment, conduct or actions due to a request for or taking such leave; (iv) Wilkinson has provided the Company with written notice of any and all concerns regarding suspected ethical and compliance issues or violations on the part of the Company; (v) Wilkinson has reported any pending judicial and administrative complaints, claims, or actions Wilkinson filed against the Company or any Released Party; and (vi) Wilkinson has not raised a claim of sexual harassment or abuse with the Company.

(b) Wilkinson agrees to cooperate with Company regarding any pending or subsequently filed litigation, claims, or other disputes involving Company that relate to matters within the knowledge or responsibility of Wilkinson during her employment with Company. Without limiting the foregoing, Wilkinson agrees (i) to meet with Company representatives, its counsel, or other designees at mutually convenient times and places with respect to any items within the scope of this provision; (ii) to provide truthful testimony regarding same to any court, agency, or other adjudicatory body; and (iii) to provide Company with notice of contact by any adverse party or such adverse party’s representative, except as may be required by law. Wilkinson shall be reimbursed for her reasonable and documented expenses and time at a market rate for such assistance.

(c) Wilkinson will not solicit, or assist or facilitate another in soliciting, for employment any natural person who as of the Effective Date is employed by the Company or any of its subsidiaries in any capacity, or personally solicit, or assist or facilitate another in soliciting, any such employees to terminate their employment with the Company or personally facilitate or assist in the hiring of any such employee by any other person for a period of six months following the Separation Date.

(d) Wilkinson is releasing all rights under section 1542 of the California Civil Code. Section 1542 provides as follows:

Page 4 of 9

Rev. 7/10/2019

A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release, and that, if known by him or her would have materially affected his or her settlement with the debtor or released party.

8.Confidentiality.

(a) Wilkinson and the Company acknowledge that by virtue of her prior relationship with the Company, Wilkinson has previously had access to certain Confidential Information and been involved in the creation of certain Confidential Information. Wilkinson acknowledges and agrees that all such Confidential Information constitutes valuable, special and unique property belonging exclusively to the Company. Wilkinson agrees that she will not, for any reason or purpose whatsoever, use or disclose any Confidential Information to any party without express written authorization of the Company.

(b) “Confidential Information” means any confidential or proprietary information of the Company, including, without limitation, all documents or information, in whatever form or medium, concerning or evidencing operations, activities, strategies, short or long range plans, financial and tax information, personnel information, plans, opportunities, intellectual property information, research and development information, data, manufacturing methods, processes, vendor information, and customer information, but excluding any such information that is or becomes generally available to the public other than as a result of any breach of this Agreement or other unauthorized disclosure.

(c) This Agreement and all terms of this Agreement are hereby designated as Confidential Information. Neither Wilkinson nor the Company, nor their agents and representatives, are permitted to discuss the nature and terms of this Agreement with any third party, other than Wilkinson’s immediate family who has agreed to keep such information confidential, except that both parties are permitted to discuss the nature and terms of this Agreement with appropriate tax, accounting or legal professionals, as may be required by securities laws or the rule of any applicable stock exchange, as necessary in any legal proceedings directly related to the provisions and terms of this Agreement, or as otherwise required by law or compelled by a court of competent jurisdiction after reasonable notice to the Company.

9.Non-Disparagement. Wilkinson agrees not to disparage the Company, its directors, officers or employees, and the Company agrees that its executive officers and senior managers will not disparage Wilkinson or her tenure or efforts at the Company.

Page 5 of 9

Rev. 7/10/2019

10.Governing Law; Choice of Venue. The execution, validity, interpretation and performance of this Agreement shall be determined and governed exclusively by the laws of the State of Texas, without reference to the principles of conflict of laws.

11.Entire Agreement. This Agreement represents the complete agreement and understanding between Wilkinson and the Company concerning the subject matter hereof and supersedes all prior agreements and understandings, written or oral, between Wilkinson and any member of the Company concerning the subject matter of this Agreement that is in conflict with this Agreement; provided, however, that for the avoidance of doubt, this Agreement and the execution and delivery thereof shall not operate as a waiver of any preexisting rights or obligations of the parties related to indemnities or insurance obligations. No attempted modification or waiver of any of the provisions of this Agreement shall be binding on any party hereto unless in writing and signed by Wilkinson and the Company. This Agreement is binding upon and inures to the benefit of the parties’ heirs, successors and permitted assigns.

12.Acknowledgements. This Agreement has been entered into voluntarily and not as a result of coercion, duress or undue influence. Wilkinson acknowledges that she has read and fully understands the terms of this Agreement. The company hereby advises Wilkinson to consult with an attorney before executing this Agreement. Wilkinson agrees with the Company that modifications to this Agreement, whether material or immaterial, do not restart the running of the 45-day consideration period provided in Paragraph 1. The consideration for this Agreement is in addition to anything of value to which Wilkinson already is entitled, and is not wages, a wage increase, a bonus, or any other form of compensation for services performed. Standard deductions will be made to the consideration for this Agreement. If Wilkinson is age 40 or over and Wilkinson’s termination is part of an employment termination program, the Company has attached information regarding the class, unit, or group of individuals covered by the employment termination program, the applicable eligibility factors and time limits, and a list of the job titles and ages of all individuals eligible or selected for the employment termination program as well as those who are not.

13.Dispute Resolution. Any and all disputes between the parties to this Agreement arising out of or in connection with the negotiation, execution, interpretation, performance or non-performance of this Agreement and the covenants and obligations contemplated herein, including but not limited to any claims against Wilkinson, the Company, its respective officers, directors, employees or agents, shall be solely and finally settled by arbitration before three arbitrators conducted in Houston, Texas pursuant to the Commercial Rules of the American Arbitration Association, as now in effect or hereafter amended. Judgment on the award of the arbitrator may be entered in any court having jurisdiction over the party against whom enforcement of the award is being sought, and the parties hereby irrevocably consent to the jurisdiction of any such court for the purpose of enforcing any such award. The parties agree and acknowledge that any arbitration

Page 6 of 9

Rev. 7/10/2019

proceedings between them, and the outcome of such proceedings, shall be kept strictly confidential. In the event of any such dispute concerning the subject matter of this Agreement, the prevailing party shall be entitled to recover reasonable attorney’s fees and costs incurred for the arbitration.

14.Notices. All notices, consents, waivers and other communications required or permitted by this Agreement shall be in writing and shall be deemed given to a party when (a) delivered to the appropriate address by hand or by nationally recognized overnight courier service (costs prepaid); (b) sent by facsimile or e-mail with confirmation of transmission by the transmitting equipment; or (c) received or rejected by the addressee, if sent by certified mail, return receipt requested, in each case to the following addresses, facsimile numbers or e-mail addresses and marked to the attention of the person (by name or title) designated below (or to such other address, facsimile number, e-mail address or person as a party may designate by notice to the other parties):

Company:

Flotek Industries, Inc.

Attention: HR Director

8846 N. Sam Houston Parkway W. Suite 150

Houston, Texas 77064

with a mandatory copy by email to: legal@flotekind.com

Wilkinson:

Elizabeth Wilkinson

827 Greenbelt Dr.

Houston, TX 77079

with a mandatory copy by email to: etwilkinson@yahoo.com

15.Execution. This Agreement may be executed in counterparts, each of which will be deemed an original and shall be deemed duly executed upon the signing of the counterparts by the parties. This Agreement may be executed by facsimile or .pdf signature and a facsimile or .pdf signature shall constitute an original for all purposes.

16.Exceptions and No Interference with Rights. Wilkinson understands this Agreement does not apply to (a) any claims or rights that may arise after the date that

Page 7 of 9

Rev. 7/10/2019

Wilkinson signed this Agreement, (b) the Company’s expense reimbursement policies, (c) any vested rights under the Company’s ERISA-covered employee benefit plans as applicable on the date Wilkinson sign this Agreement, and (d) any claims that the controlling law clearly states may not be released by private agreement. Moreover, nothing in this Agreement (including but not limited to the acknowledgements, release of claims, the promise not to sue, the confidentiality obligations, and the return of property provision) (w) waives Wilkinson’s right to testify in an administrative, legislative, or judicial proceeding concerning alleged criminal conduct or alleged sexual harassment on the part of the Company, or on the part of the agents or employees of the Company, when Wilkinson has been required or requested to attend such a proceeding pursuant to a court order, subpoena, or written request from an administrative agency or the legislature, (x) limits or affects Wilkinson’s right to challenge the validity of this Agreement under the ADEA or the OWBPA, (y) prevents Wilkinson from communicating with, filing a charge or complaint with, or from participating in an investigation or proceeding conducted by the EEOC, the National Labor Relations Board, the Securities and Exchange Commission, or any other federal, state or local agency charged with the enforcement of any laws, including providing documents or any other information, or (z) precludes Wilkinson from exercising her rights under Section 7 of the NLRA to engage in protected, concerted activity with other employees, although by signing this Agreement Wilkinson is waiving her right to recover any individual relief (including any backpay, frontpay, reinstatement or other legal or equitable relief) in any charge, complaint, or lawsuit or other proceeding brought by Wilkinson or on her behalf by any third party, except for any right Wilkinson may have to receive a payment or award from a government agency (and not the Company) for information provided to the government agency or where otherwise prohibited.

The parties to this Agreement executed this Agreement on the dates set forth below.

/s/ Elizabeth Wilkinson

____________________________________

Elizabeth Wilkinson

7/28/2020

Date

Page 8 of 9

Rev. 7/10/2019

FLOTEK INDUSTRIES, INC.

By: /s/DanielleAllen

Name: Danielle Allen

Title: SVP, Chief of Staff

7/28/2020

Date

Page 9 of 9

Exhibit

Exhibit 31.1

CERTIFICATION

I, John W. Gibson, Jr., certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Flotek Industries, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ JOHN W. GIBSON, JR.

John W. Gibson, Jr.

President, Chief Executive Officer and Chairman of the Board

Date: August 17, 2020

Exhibit

Exhibit 31.2

CERTIFICATION

I, Michael Borton, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Flotek Industries, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ MICHAEL BORTON

Michael Borton

Chief Financial Officer

Date: August 17, 2020

Exhibit

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Flotek Industries, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ JOHN W. GIBSON, JR.

John W. Gibson, Jr.

President, Chief Executive Officer and Chairman of the Board

Date: August 17, 2020

Exhibit

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ MICHAEL BORTON

Michael Borton

Chief Financial Officer

Date: August 17, 2020

Cover - shares	6 Months Ended
Cover - shares	Jun. 30, 2020	Aug. 04, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2020
Document Transition Report	false
Entity File Number	1-13270
Entity Incorporation, State	DE
Entity Tax Identification Number	90-0023731
Entity Address, Address Line One	8846 N. Sam Houston Parkway W.
Entity Address, City or Town	Houston,
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77064
City Area Code	713
Local Phone Number	849-9911
Title of each class	Common Stock, $0.0001 par value
Trading Symbol(s)	FTK
Name of each exchange on which registered	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		71,306,770
Entity Registrant Name	FLOTEK INDUSTRIES INC/CN
Entity Central Index Key	0000928054
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Amendment Flag	false

Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 59,926	$ 100,575
Restricted cash	664	663
Accounts receivable, net of allowance for doubtful accounts of $1,383 and $1,527 at June 30, 2020 and December 31, 2019, respectively	8,108	15,638
Inventories, net	23,338	23,210
Income taxes receivable	6,846	631
Other current assets	2,407	13,191
Total current assets	101,289	153,908
Property and equipment, net	8,017	39,829
Operating lease right-of-use assets	2,422	16,388
Goodwill	17,522	0
Deferred tax assets, net	152	152
Other intangible assets, net	12,777	20,323
Other long-term assets	17	0
TOTAL ASSETS	142,196	230,600
Current liabilities:
Accounts payable	7,876	16,231
Accrued liabilities	10,474	24,552
Income taxes payable	12	0
Current portion of long-term debt	2,527	0
Current portion of operating lease liabilities	654	486
Current portion of finance lease liabilities	57	55
Total current liabilities	21,600	41,324
Long-term debt, less current portion	3,144	0
Deferred revenue, long-term	111	0
Long-term operating lease liabilities	8,497	16,973
Long-term finance lease liabilities	127	158
Deferred tax liabilities, net	11	116
Total liabilities	33,490	58,571
Commitments and contingencies (See Note 19)
Stockholders’ equity:
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.0001 par value, 140,000,000 shares authorized; 77,626,135 shares issued and 73,166,719 shares outstanding at June 30, 2020; 63,656,897 shares issued and 59,511,416 shares outstanding at December 31, 2019	7	6
Additional paid-in capital	357,980	347,564
Accumulated other comprehensive income	51	181
Retained earnings (accumulated deficit)	(215,766)	(142,238)
Treasury stock, at cost; 4,459,416 and 4,145,481 shares at June 30, 2020 and December 31, 2019, respectively	(33,566)	(33,484)
Total stockholders’ equity	108,706	172,029
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 142,196	$ 230,600

Unaudited Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 1,383	$ 1,527
Preferred stock, at par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	100,000	100,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	140,000,000	140,000,000
Common stock, shares issued (in shares)	77,626,135	63,656,897
Common stock, shares outstanding (in shares)	73,166,719	59,511,416
Treasury stock, shares (in shares)	4,459,416	4,145,481

Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Statement [Abstract]
Revenue	$ 8,880	$ 34,692	$ 28,296	$ 77,949
Costs and expenses:
Operating expenses (excluding depreciation and amortization)	11,632	38,121	34,473	82,089
Corporate general and administrative	5,395	6,054	9,888	13,335
Depreciation and amortization	468	2,119	2,659	4,379
Research and development	1,638	2,076	4,193	4,360
(Gain) loss on disposal of long-lived assets	(22)	(4)	(55)	1,093
Impairment of fixed and long-lived assets	0	0	57,454	0
Total costs and expenses	19,111	48,366	108,612	105,256
Loss from operations	(10,231)	(13,674)	(80,316)	(27,307)
Other (expense) income:
Gain on lease termination	576	0	576	0
Interest expense	(16)	(16)	(20)	(2,013)
Other income, net	78	693	31	800
Total other expense, net	638	677	587	(1,213)
Loss before income taxes	(9,593)	(12,997)	(79,729)	(28,520)
Income tax benefit	32	192	6,201	503
Loss from continuing operations	(9,561)	(12,805)	(73,528)	(28,017)
(Loss) income from discontinued operations, net of tax	0	(1,608)	0	44,466
Net (loss) income	$ (9,561)	$ (14,413)	$ (73,528)	$ 16,449
Basic earnings (loss) per common share:
Continuing operations (in dollars per share)	$ (0.14)	$ (0.22)	$ (1.17)	$ (0.48)
Discontinued operations, net of tax (in dollars per share)	0	(0.03)	0	0.76
Basic earnings (loss) per common share (in dollars per share)	(0.14)	(0.25)	(1.17)	0.28
Diluted earnings (loss) per common share:
Continuing operations (in dollars per share)	(0.14)	(0.22)	(1.17)	(0.48)
Discontinued operations, net of tax (in dollars per share)	0	(0.03)	0	0.76
Diluted earnings (loss) per common share (in dollars per share)	$ (0.14)	$ (0.25)	$ (1.17)	$ 0.28
Weighted average common shares:
Weighted average common shares used in computing basic earnings (loss) per common share (in shares)	66,035	58,608	62,828	58,491
Weighted average common shares used in computing diluted earnings (loss) per common share (in shares)	66,035	58,608	62,828	58,491

Unaudited Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Statement of Comprehensive Income [Abstract]
Loss from continuing operations	$ (9,561)	$ (12,805)	$ (73,528)	$ (28,017)
(Loss) income from discontinued operations, net of tax	0	(1,608)	0	44,466
Net (loss) income	(9,561)	(14,413)	(73,528)	16,449
Other comprehensive (loss) income:
Foreign currency translation adjustment	(7)	24	(130)	118
Comprehensive (loss) income	$ (9,568)	$ (14,389)	$ (73,658)	$ 16,567

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended					6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2019	Dec. 31, 2019
Cash flows from operating activities:
Net (loss) income attributable to Flotek Industries, Inc.	$ (9,561)			$ (14,413)		$ (73,528)	$ 16,449
Less: Income from discontinued operations, net of tax	0			(1,608)		0	44,466
Loss from continuing operations	(9,561)			(12,805)		(73,528)	(28,017)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization	468			2,119		2,659	4,379
Amortization of deferred financing costs						0	1,428
Provision for doubtful accounts						474	102
Provision for excess and obsolete inventory						529	0
Impairment of right-of-use assets						7,434	0
Impairment of fixed assets						30,178	0
Impairment of intangible assets						19,842	0
(Gain)/loss on disposal of long-lived assets						(631)	1,093
Non-cash lease expense						242	464
Stock compensation expense						1,521	1,669
Deferred income tax provision						(105)	17,855
Reduction in tax benefit related to share-based awards						0	24
Changes in current assets and liabilities:
Accounts receivable, net						7,252	6,289
Inventories, net						6,418	554
Income taxes receivable						(6,351)	(281)
Other current assets		$ 3,645	$ (4,036)		$ (4,442)	1,715	(1,990)		$ 2,579
Other long-term assets			(3,286)		(3,286)	0	(3,286)		(4,417)
Accounts payable						(10,229)	(4,157)
Accrued liabilities						(16,755)	(10,216)
Income taxes payable						119	1,182
Interest payable						0	(8)
Net cash used in operating activities						(29,216)	(6,344)
Cash flows from investing activities:
Capital expenditures	0			(306)		(42)	(767)
Proceeds from sale of business		3,281			152,217	9,844	152,217	$ 155,498	155,498
Proceeds from sale of assets						66	140
Purchase of JP3, net of cash acquired						(26,284)	0
Purchase of patents and other intangible assets						(8)	(227)
Net cash (used in) provided by investing activities						(16,424)	151,363
Cash flows from financing activities:
Borrowings on revolving credit facility						0	42,984
Repayments on revolving credit facility						0	(92,715)
Proceeds from Paycheck Protection Program loan						4,798
Purchase of treasury stock related to share-based awards						(82)	(142)
Proceeds from sale of common stock						358	0
Payments for finance leases	(14)			(38)		(51)	(38)
Net cash provided by (used in) financing activities						5,023	(49,911)
Discontinued operations:
Net cash used in operating activities						0	(321)
Net cash provided by investing activities						0	337
Net cash flows provided by discontinued operations						0	16
Effect of changes in exchange rates on cash and cash equivalents						(31)	2
Net (decrease) increase in cash and cash equivalents and restricted cash						(40,648)	95,126
Cash and cash equivalents at the beginning of period		100,575	97,509		3,044	100,575	3,044	3,044	3,044
Restricted cash at the beginning of period		663	661		0	663	0	0	0
Cash and cash equivalents and restricted cash at beginning of period		$ 101,238	$ 98,170		$ 3,044	101,238	3,044	$ 3,044	3,044
Cash and cash equivalents at end of period	59,926			97,509		59,926	97,509		100,575
Restricted cash at the end of period	664			661		664	661		663
Cash and cash equivalents and restricted cash at the end of period	$ 60,590			$ 98,170		$ 60,590	$ 98,170		$ 101,238

Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Accumulated Deficit)
Beginning balance at Dec. 31, 2018	$ 202,013	$ 6	$ (33,237)	$ 343,536	$ 31	$ (108,323)
Beginning balance (in shares) at Dec. 31, 2018		62,163,000	3,770,000
Increase (Decrease) in Equity
Net (loss) income	16,449					16,449
Foreign currency translation adjustment	118				118
Restricted stock granted (in shares)		793,000
Restricted stock forfeited (in shares)			133,000
Treasury stock purchased	(141)		$ (141)
Treasury stock purchased (in shares)			45,000
Stock compensation expense	1,681			1,681
Stock issued in JP3 acquisition	0
Ending balance at Jun. 30, 2019	220,120	$ 6	$ (33,378)	345,217	149	(91,874)
Ending balance (in shares) at Jun. 30, 2019		62,956,000	3,948,000
Beginning balance at Mar. 31, 2019	233,306	$ 6	$ (33,368)	344,004	125	(77,461)
Beginning balance (in shares) at Mar. 31, 2019		62,199,000	3,845,000
Increase (Decrease) in Equity
Net (loss) income	(14,413)					(14,413)
Foreign currency translation adjustment	24				24
Restricted stock granted (in shares)		757,000
Restricted stock forfeited (in shares)			99,000
Treasury stock purchased	(10)		$ (10)
Treasury stock purchased (in shares)			4,000
Stock compensation expense	1,213			1,213
Ending balance at Jun. 30, 2019	220,120	$ 6	$ (33,378)	345,217	149	(91,874)
Ending balance (in shares) at Jun. 30, 2019		62,956,000	3,948,000
Beginning balance at Dec. 31, 2019	172,029	$ 6	$ (33,484)	347,564	181	(142,238)
Beginning balance (in shares) at Dec. 31, 2019		63,657,000	4,145,000
Increase (Decrease) in Equity
Net (loss) income	(73,528)					(73,528)
Foreign currency translation adjustment	(130)				(130)
Stock issued under employee stock purchase plan	20			20
Stock issued under employee stock purchase plan (in shares)			(25,000)
Restricted stock granted	$ 338			338
Restricted stock granted (in shares)	2,469,238	2,469,000
Restricted stock forfeited (in shares)			278,000
Treasury stock purchased	$ (82)		$ (82)
Treasury stock purchased (in shares)			61,000
Stock compensation expense	1,521			1,521
Stock issued in JP3 acquisition	$ 8,538	$ 1		8,537
Stock issued in JP3 acquisition (shares)	11,500,000	11,500,000
Ending balance at Jun. 30, 2020	$ 108,706	$ 7	$ (33,566)	357,980	51	(215,766)
Ending balance (in shares) at Jun. 30, 2020		77,626,000	4,459,000
Beginning balance at Mar. 31, 2020	108,705	$ 6	$ (33,529)	348,375	58	(206,205)
Beginning balance (in shares) at Mar. 31, 2020		64,338,000	4,395,000
Increase (Decrease) in Equity
Net (loss) income	(9,561)					(9,561)
Foreign currency translation adjustment	(7)				(7)
Stock issued under employee stock purchase plan	9			9
Stock issued under employee stock purchase plan (in shares)			(12,000)
Restricted stock granted (in shares)		1,788,000
Restricted stock forfeited (in shares)			37,000
Treasury stock purchased	(37)		$ (37)
Treasury stock purchased (in shares)			39,000
Stock compensation expense	1,059			1,059
Stock issued in JP3 acquisition	8,538	$ 1		8,537
Stock issued in JP3 acquisition (shares)		11,500,000
Ending balance at Jun. 30, 2020	$ 108,706	$ 7	$ (33,566)	$ 357,980	$ 51	$ (215,766)
Ending balance (in shares) at Jun. 30, 2020		77,626,000	4,459,000

Organization and Significant Accounting Policies	6 Months Ended
Organization and Significant Accounting Policies	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Significant Accounting Policies	Organization and Significant Accounting Policies Organization and Nature of Operations Flotek Industries, Inc. (“Flotek” or the “Company”) is a technology-driven international chemistry and data company that develops and supplies chemistries, services, equipment and data analytics to industrial, commercial and consumer markets. During the second quarter of 2020, the Company acquired 100% ownership of JP3 Measurement, LLC (“JP3”), a privately-held leading data and analytics technology company, in a cash-and-stock transaction. JP3’s real-time data platforms combine the energy industry’s only field-deployable, inline optical analyzer with proprietary cloud visualization and analytics, targeting an increase of processing efficiencies and valuation of natural gas, crude oil, and refined fuels. The transaction was valued at approximately $36.6 million, as of the transaction closing date, comprised of $25.0 million in cash subject to certain adjustments and contingent consideration and 11.5 million shares in Flotek common stock with an estimated fair value of $8.5 million, net of a discount for marketability due to a lock-up period. The payment of $25.0 million was subject to certain purchase price adjustments, and the total non-equity consideration at closing was comprised of $25.0 million plus net working capital in excess of the target net working capital of $1.9 million and contingent consideration of an estimated $1.2 million for two potential earn-out provisions totaling $5.0 million based on certain stock performance targets. With the acquisition of JP3, the Company evaluated its segment information and determined that there were two segments: Chemistry Technologies and Data Analytics, which are both supported by its continuing Research & Innovation advanced laboratory capabilities. The Company’s Chemistry Technologies segment includes specialty chemistries, logistics and technology services. The Company designs, develops, manufactures, packages, distributes, delivers, and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in oil and gas well drilling, cementing, completion, remediation, and stimulation activities designed to maximize recovery in both new and mature fields. Customers of the Chemistry Technologies business segment include major integrated oil and gas companies, oilfield services companies, independent oil and gas companies, pressure-pumping service companies, national and state-owned oil companies, and international supply chain management companies. In the second quarter of 2020, the Chemistry Technologies segment launched a line of sanitizers and disinfectants for commercial and personal consumer use. These products build on the Company’s historical expertise in chemistry and leverage its infrastructure, personnel, competencies, supply chain, research, and historic consumer market experiences, yielding a competitive product offering in this rapidly growing area. The newly-launched products include hand sanitizers for retail and e-commerce sales and disinfecting liquids for use in and by hospitals, first responders, the travel and hospitality industry, food services, sporting facilities, and other commercial and industrial applications. The Company’s Data Analytics segment, created in conjunction with the acquisition of JP3, includes the design, development, production, sale and support of equipment and services that create and provide valuable information about the composition of its energy customers’ hydrocarbon streams. The customers of the Data Analytics segment span across the entire market, from production upstream to midstream facilities to refineries and distribution networks. To date, the Data Analytics segment has focused solely on North American markets. The Data Analytics segment provides real-time hydrocarbon composition data that helps its customers generate additional profit by enhancing blending, increasing efficiencies of towers, enabling automation and robotization of fluid handling, and reducing losses due to give-away. Flotek was initially incorporated under the laws of the Province of British Columbia on May 17, 1985. On October 23, 2001, Flotek changed its corporate domicile to the state of Delaware. Basis of Presentation The accompanying Financial Statements reflect all adjustments, in the opinion of management, necessary for fair presentation of the financial condition and results of operations for the periods presented. All such adjustments are normal and recurring in nature. The Financial Statements, including selected notes, have been prepared in accordance with applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and do not include all information and disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for comprehensive financial statement reporting. These interim Financial Statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (“2019Annual Report”) as amended by the Amendment No. 2 on Form 10-K/A to the 2019 Annual Report, filed with the SEC on June 11, 2020. A copy of the 2019 Annual Report is available on the SEC’s website, www.sec.gov, under the Company’s ticker symbol (“FTK”) or on Flotek’s website, www.flotekind.com. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company does not have investments in any unconsolidated subsidiaries. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates. Potential Impact of COVID-19 On March 11, 2020, the World Health Organization declared the outbreak of the novel coronavirus (“COVID-19”) a global pandemic, which continues to spread throughout the United States and around the world. This outbreak has severely impacted global economic activity, and many countries and many states in the United States have reacted to the outbreak by instituting quarantines, mandating business and school closures and restricting travel. In addition, global oil producers, including the Organization of Petroleum Exporting Countries and other oil producing nations, have experienced disagreements relating to oil production which has led to downward pressure on commodity prices. The effects of the COVID-19 pandemic, including actions taken by businesses and governments, have resulted in a significant and swift reduction in international and U.S. economic activity. These effects and the volatility in oil prices have materially and adversely affected, and may continue to materially and adversely affect, the demand for oil and natural gas. The Company’s primary markets in Texas are particularly subject to the financial impact of a collapse in oil prices. In the second quarter of 2020, these conditions and the related financial impact have continued and, in some cases, worsened. As a result, the Company has recorded an impairment to property, plant and equipment, intangible assets, and operating right-of-use assets during the first quarter of 2020. In addition, the Company adopted social distancing and work-from-home procedures, which have had and may continue to have an impact on the ability of employees and management of the Company to communicate and work efficiently. In response to the deteriorating market conditions and anticipating ongoing volatility, the Company has also reduced its cost structure to meet anticipated market activity and reduce the Company’s break-even levels. Among other cost-cutting initiatives: • The Company’s CEO, John W. Gibson, Jr., reduced his base salary by 20%, and each of the other executive officers reduced his or her salary by 10% , through December 31, 2020 in exchange for restricted stock, effective as of April 1, 2020. • The board of directors of Flotek approved a 20% reduction in the fees to be paid to the directors, effective as of April 1, 2020. • The Company consolidated office space by moving all employees at its corporate headquarters into the Houston Global Resource and Innovation Center, (“GRIC”) facility and buying out the remaining term of the corporate headquarters lease for a significant discount, with the move completed by the end of June 2020. • The Company reduced headcount by 35% on March 30, 2020. While the full impact of the COVID-19 outbreak is not yet known, we are closely monitoring the effects of the pandemic on commodity demands and on our customers, as well as on our operations and employees. Any future development and effects will be highly uncertain and cannot be predicted, including the scope and duration of the pandemic; further adverse revenue and net income effects; disruptions to our operations; third party providers’ ability to support our operations; customer shutdowns of oil and gas exploration and production; the effectiveness of our work from home arrangements; employee impacts from illness, school closures and other community response measures; any actions taken by governmental authorities and other third parties in response to the pandemic; and temporary closures of our facilities or the facilities of our customers and suppliers. Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did not impact previously reported net loss and stockholders’ equity.

Recent Accounting Pronouncements	6 Months Ended
Recent Accounting Pronouncements	Jun. 30, 2020
Accounting Standards Update and Change in Accounting Principle [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements Application of New Accounting Standards Effective January 1, 2019, the Company adopted the accounting guidance in Accounting Standards Update (“ASU”) No. 2016-02, “Leases.” This standard (ASC 842) requires the recognition of Right-Of-Use (“ROU”) assets and lease liabilities by lessees for those leases classified as operating leases under previous U.S. GAAP (ASC 840). Upon adoption, the Company recorded operating lease ROU assets and corresponding operating lease liabilities, net of deferred rent, representing the present value of future lease payments under operating leases with terms of greater than twelve months. The adoption of this standard did not have a material impact on the consolidated statements of operations or cash flows. Refer to Note 5 — “Leases” for further information surrounding adoption of this new standard. Effective January 1, 2019, the Company adopted ASU No. 2018-02, “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” This standard allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the 2017 Tax Cuts and Jobs Act. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. Effective January 1, 2019, the Company adopted ASU No. 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting.” This standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. New Accounting Requirements and Disclosures Effective January 1, 2020, the Company adopted ASU No. 2018-13, “Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement.” This standard removes, modifies, and adds additional requirements for disclosures related to fair value measurement in ASC 820. The pronouncement is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted in any interim period. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. New Accounting Standards to be Adopted The Financial Accounting Standards Board (“FASB”) issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This standard removes specific exceptions to the general principles in Topic 740. The pronouncement is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years, with early adoption permitted for public companies for periods in which financial statements have not yet been issued. The Company is currently evaluating the impact of this standard on the consolidated financial statements and related disclosures. The FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments.” This standard replaces the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The pronouncement is effective for smaller reporting companies for fiscal years beginning after December 15, 2022. The Company is currently evaluating the impact of this standard on the consolidated financial statements and related disclosures.

Acquisition of JP3 Measurement LLC

6 Months Ended

Jun. 30, 2020

Business Combinations [Abstract]

Acquisition of JP3 Measurement LLC

The following table summarizes the fair value of JP3’s assets acquired as of the closing date of May 18, 2020 (in thousands) :



Tradenames and trademarks	$	1,100
Technology and know-how	5,000
Customer relationships	6,800
Inventory	7,100
Cash	604
Net working capital, net of cash and inventory	(1,063		)
Fixed assets	426
Long-term debt assumed and other assets (liabilities)	(893		)
Goodwill	17,522
Net assets acquired	$	36,596

Pro forma information for JP3 is not provided as the impact is not considered material.

Discontinued Operations

6 Months Ended

Jun. 30, 2020

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations



	Three months ended June 30,					Six months ended June 30,
	2020		2019			2020		2019
Consumer and Industrial Chemistry Technologies
Revenue	$	—	$	—		$	—	$	10,877
Operating expenses	—		—			—		(11,447		)
Research and development	—		—			—		(69		)
(Loss) income from operations	—		—			—		(639		)
Other income	—		—			—		35
Gain on sale of business	—		(2,100		)	—		64,934
(Loss) Income before income taxes	—		(2,100		)	—		64,330
Income tax benefit (expense)	—		492			—		(19,864		)
Net (loss) income from discontinued operations	$	—	$	(1,608	)	$	—	$	44,466

Leases

6 Months Ended

Jun. 30, 2020

Leases [Abstract]

Leases

The components of lease expense and supplemental cash flow information are as follows (in thousands):



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Operating lease expense	$	283	$	653	$	854	$	1,306
Finance lease expense:
Amortization of right-of-use assets	4		220		9		220
Interest on lease liabilities	5		3		9		3
Total finance lease expense	9		223		18		223
Short-term lease expense	54		32		86		75
Total lease expense	$	346	$	908	$	958	$	1,604

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	1,411	$	583	$	1,024	$	1,165
Operating cash flows from finance leases	5		3		9		3
Financing cash flows from finance leases	14		38		51		38

Maturities of lease liabilities are as follows (in thousands):



Years ending December 31,	Operating Leases			Finance Leases
2020 (excluding the six months ended June 30, 2020)	$	617		$	33
2021	1,330			70
2022	1,283			47
2023	1,311			39
2024	1,341			23
Thereafter	8,185			—
Total lease payments	$	14,067		$	212
Less: Interest	(4,916		)	(28		)
Present value of lease liabilities	$	9,151		$	184

Supplemental balance sheet information related to leases is as follows (in thousands):



	June 30, 2020			December 31, 2019
Operating Leases
Operating lease right-of-use assets	$	2,422		$	16,388

Current portion of operating lease liabilities	$	654		$	486
Long-term operating lease liabilities	8,497			16,973
Total operating lease liabilities	$	9,151		$	17,459

Finance Leases
Property and equipment	$	147		$	293
Accumulated depreciation	(18		)	(28		)
Property and equipment, net	$	129		$	265

Current portion of finance lease liabilities	$	57		$	55
Long-term finance lease liabilities	127			158
Total finance lease liabilities	$	184		$	213

Weighted Average Remaining Lease Term
Operating leases	10.1 years			16.6 years
Finance leases	4.1 years			4.6 years

Weighted Average Discount Rate
Operating leases	8.9		%	8.9		%
Finance leases	8.5		%	9.0		%

Leases

The components of lease expense and supplemental cash flow information are as follows (in thousands):



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Operating lease expense	$	283	$	653	$	854	$	1,306
Finance lease expense:
Amortization of right-of-use assets	4		220		9		220
Interest on lease liabilities	5		3		9		3
Total finance lease expense	9		223		18		223
Short-term lease expense	54		32		86		75
Total lease expense	$	346	$	908	$	958	$	1,604

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	1,411	$	583	$	1,024	$	1,165
Operating cash flows from finance leases	5		3		9		3
Financing cash flows from finance leases	14		38		51		38

Maturities of lease liabilities are as follows (in thousands):



Years ending December 31,	Operating Leases			Finance Leases
2020 (excluding the six months ended June 30, 2020)	$	617		$	33
2021	1,330			70
2022	1,283			47
2023	1,311			39
2024	1,341			23
Thereafter	8,185			—
Total lease payments	$	14,067		$	212
Less: Interest	(4,916		)	(28		)
Present value of lease liabilities	$	9,151		$	184

Supplemental balance sheet information related to leases is as follows (in thousands):



	June 30, 2020			December 31, 2019
Operating Leases
Operating lease right-of-use assets	$	2,422		$	16,388

Current portion of operating lease liabilities	$	654		$	486
Long-term operating lease liabilities	8,497			16,973
Total operating lease liabilities	$	9,151		$	17,459

Finance Leases
Property and equipment	$	147		$	293
Accumulated depreciation	(18		)	(28		)
Property and equipment, net	$	129		$	265

Current portion of finance lease liabilities	$	57		$	55
Long-term finance lease liabilities	127			158
Total finance lease liabilities	$	184		$	213

Weighted Average Remaining Lease Term
Operating leases	10.1 years			16.6 years
Finance leases	4.1 years			4.6 years

Weighted Average Discount Rate
Operating leases	8.9		%	8.9		%
Finance leases	8.5		%	9.0		%

Revenue from Contracts with Customers

6 Months Ended

Jun. 30, 2020

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

The Data Analytics segment provides services over a period of time and for those services, the revenues are recognized over time.

Disaggregation of Revenue



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Revenue:
Products	$	8,176	$	33,632	$	26,976	$	75,703
Services	704		1,060		1,320		2,246
	$	8,880	$	34,692	$	28,296	$	77,949
Operating expenses (excluding depreciation and amortization):
Products	$	11,278	$	37,613	$	33,825	$	81,062
Services	354		508		648		1,027
	$	11,632	$	38,121	$	34,473	$	82,089

Arrangements with Multiple Performance Obligations

Contract Balances

Supplemental Cash Flow Information

6 Months Ended

Jun. 30, 2020

Supplemental Cash Flow Elements [Abstract]

Supplemental Cash Flow Information

Supplemental cash flow information is as follows (in thousands):



	Six months ended June 30,
	2020		2019
Supplemental cash payment information:
Interest paid	$	20	$	594
Income taxes paid, net of refunds	149		627
Supplemental schedule of non-cash investing and financing activities:
Equity issued - acquisition of JP3	8,538		—

Inventories

6 Months Ended

Jun. 30, 2020

Inventory Disclosure [Abstract]

Inventories

Inventories are as follows (in thousands):



	June 30, 2020			December 31, 2019
Raw materials	$	4,810		$	4,339
Finished goods	20,155			24,569
Inventories	24,965			28,908
Less reserve for excess and obsolete inventory	(1,627		)	(5,698		)
Inventories, net	$	23,338		$	23,210

Property and Equipment

6 Months Ended

Jun. 30, 2020

Property, Plant and Equipment [Abstract]

Property and Equipment

Property and equipment are as follows (in thousands):



	June 30, 2020			December 31, 2019
Land	$	3,282		$	4,440
Buildings and leasehold improvements	6,048			38,741
Machinery and equipment	7,227			27,694
Furniture and fixtures	643			1,671
Transportation equipment	1,190			1,440
Computer equipment and software	1,296			3,348
Property and equipment	19,686			77,334
Less accumulated depreciation	(11,669		)	(37,505		)
Property and equipment, net	$	8,017		$	39,829

Depreciation expense totaled $0.3 million and $1.6 million for the three months ended June 30, 2020 and 2019, and $2.0 million and $3.4 million for the six months ended June 30, 2020 and 2019.

During the six months ended June 30, 2020 an impairment was recognized for $30.2 million. No impairment was recognized for the three months ended June 30, 2020.

Impairment of Fixed and Long-lived Assets

6 Months Ended

Jun. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Impairment of Fixed and Long-lived Assets

The Company recorded impairment charges during the six months ended June 30, 2020 as follows (in thousands):



Property and equipment, net	$	30,178
Operating lease right-of-use assets	7,434

Other Intangibles:
Patents	9,902
Customer Lists	9,165
Intangibles assets in progress	596
Trademarks and brand names	179
Total Other Intangibles	19,842

Total Impairment of fixed and long-lived assets	$	57,454

With the acquisition of JP3, the Company evaluated its segment information and determined that there were two segments: Chemistry Technologies and Data Analytics, which are both supported by its Research & Innovation advanced laboratory capabilities.

Goodwill

6 Months Ended

Jun. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

Goodwill associated with the acquisition of JP3 on May 18, 2020 is as follows (in thousands):



Goodwill at December 31, 2019	$	—
Goodwill from acquisition of JP3	17,522
Goodwill at June 30, 2020	$	17,522

Other Intangible Assets

6 Months Ended

Jun. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Other Intangible Assets

Other intangible assets are as follows (in thousands):



	June 30, 2020				December 31, 2019
	Cost		Accumulated Amortization		Cost		Accumulated Amortization
Finite-lived intangible assets:
Patents and technology	$	5,000	$	55	$	17,493	$	6,715
Customer lists	6,800		55		15,367		6,013
Trademarks and brand names	1,100		13		1,351		1,160
Total finite-lived intangible assets	$	12,900	123		$	34,211	13,888

Carrying value:
Other intangible assets, net	$	12,777			$	20,323

Amortization of finite-lived intangible assets acquired totaled $0.1 million and $0.5 million for the three months and six months ended June 30, 2019 and 2019 respectively.

Earnings (Loss) Per Share	6 Months Ended
Earnings (Loss) Per Share	Jun. 30, 2020
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	Earnings (Loss) Per Share Basic earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding combined with dilutive common share equivalents outstanding, if the effect is dilutive. Potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and six months ended June 30, 2020 and 2019, since including them would have an anti-dilutive effect on loss per share due to the net loss incurred during the periods. Securities convertible into shares of common stock that were not considered in the diluted loss per share calculations were 0.4 million restricted stock units and 4.0 million stock options for the three and six months ended June 30, 2020 and 0.7 million restricted stock units for the three and six months ended June 30, 2019.

Fair Value Measurements

6 Months Ended

Jun. 30, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurements


•	Level 1 — Quoted prices in active markets for identical assets or liabilities;


•	Level 2 — Observable inputs other than Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and


•	Level 3 — Significant unobservable inputs that are supported by little or no market activity or that are based on the reporting entity’s assumptions about the inputs.

Fair Value of Other Financial Instruments

Liabilities Measured at Fair Value on a Recurring Basis



							Balance at June 30,								Balance at December 31,
	Level 1		Level 2		Level 3		2020		Level 1		Level 2		Level 3		2019
Contingent consideration	$	—	$	—	$	1,200	$	1,200	$	—	$	—	$	—	$	—

There were no transfers in or out of either Level 1, Level 2, or Level 3 fair measurements during the periods ending June 30, 2020 and December 31, 2019.

Assets Measured at Fair Value on a Nonrecurring Basis

Level 3 Rollforward for Assets and Liabilities Measured at Fair Value on a Recurring Basis



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Balance - beginning of period	$	—	$	—	$	—	$	—
Additions / issuances	1,200		—		1,200		—
Gains (losses) recognized in earnings	—		—		—		—
Payments	—		—		—		—
Balance - end of period	$	1,200	$	—	$	1,200	$	—

Debt

6 Months Ended

Jun. 30, 2020

Debt Disclosure [Abstract]

Debt

Long-term debt, including current portion is as follows (in thousands):



	June 30, 2020
Current Portion of Long-Term Debt
Flotek PPP Loan	$	2,138
JP3 PPP Loan	389
Total current portion of long-term debt	$	2,527

Long-term debt:
Flotek PPP Loan	$	2,660
JP3 PPP Loan	484
Total long-term debt	$	3,144

Income Taxes

6 Months Ended

Jun. 30, 2020

Income Tax Disclosure [Abstract]

Income Taxes

A reconciliation of the U.S. federal statutory tax rate to the Company’s effective income tax rate is as follows:



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
U.S. federal statutory tax rate	21.0	%	21.0	%	21.0	%	21.0	%
State income taxes, net of federal benefit	0.4		1.7		—		1.0
Non-U.S. income taxed at different rates	0.9		0.7		0.2		1.0
Reduction in tax benefit related to stock-based awards	0.9		(1.1	)	(0.1	)	(1.8	)
Non-deductible expenses	0.7		—		—		(0.3	)
Research and development credit	0.1		0.4		—		0.6
Increase in valuation allowance	(23.7	)	(20.7	)	(16.0	)	(17.9	)
Effect of tax rate differences of NOL carryback	—		—		2.6		—
Other	—		(0.4	)	—		(0.3	)
Effective income tax rate	0.3	%	1.6	%	7.7	%	3.3	%

federal NOLs. The Company continues to have a full valuation allowance against net deferred tax assets as it is not more-likely-than-not they will be utilized.

Common Stock

6 Months Ended

Jun. 30, 2020

Equity [Abstract]

Common Stock

A reconciliation of changes in common shares issued during the six months ended June 30, 2020 is as follows:



Shares issued at December 31, 2019	63,656,897
Issued to purchase JP3	11,500,000
Issued as restricted stock award grants	2,469,238
Shares issued at June 30, 2020	77,626,135

On June 9, 2020, the board of directors of the Company rescinded the authorization to repurchase the Company’s stock that had been previously approved in June 2015.

Business Segment, Geographic and Major Customer Information

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

Business Segment, Geographic and Major Customer Information

Segment Information

The Chemistry Technologies segment includes specialty chemistries and logistics which enable its customers to pursue improved efficiencies in the drilling and completion of their wells.

Summarized financial information of the reportable segments is as follows (in thousands):



For the three months ended June 30,	Chemistry Technologies			Data Analytics⁽¹⁾			Corporate and Other			Total
2020
Net revenue from external customers	$	7,962		$	918		$	—		$	8,880
Loss from operations, including impairment	(3,596		)	(1,151		)	(5,484		)	(10,231		)
Depreciation and amortization	246			131			91			468
Capital expenditures	—			—			—			—

2019
Net revenue from external customers	$	34,692		$	—		$	—		$	34,692
Loss from operations	(7,651		)	—			(6,023		)	(13,674		)
Depreciation and amortization	1,933			—			186			2,119
Capital expenditures	306			—			—			306



For the six months ended June 30,	Chemistry Technologies			Data Analytics⁽¹⁾			Corporate and Other			Total
2020
Net revenue from external customers	$	27,378		$	918		$	—		$	28,296
Loss from operations, including impairment	(66,257		)	(1,151		)	(12,908		)	(80,316		)
Depreciation and amortization	2,056			131			472			2,659
Capital expenditures	42			—			—			42

2019
Net revenue from external customers	$	77,949		$	—		$	—		$	77,949
Loss from operations	(12,984		)	—			(14,323		)	(27,307		)
Depreciation and amortization	3,718			—			661			4,379
Capital expenditures	767			—			—			767

⁽¹⁾The financial information disclosed above for Data Analytics is for the period May 18, 2020 to June 30, 2020.

Assets of the Company by reportable segments are as follows (in thousands):



	June 30, 2020		December 31, 2019
Chemistry Technologies	$	34,439	$	116,110
Data Analytics	40,922		—
Corporate and Other	66,835		114,490
Total assets	$	142,196	$	230,600

Geographic Information



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
U.S.	$	6,936	$	31,114	$	22,711	$	69,990
Other countries	1,944		3,578		5,585		7,959
Total	$	8,880	$	34,692	$	28,296	$	77,949

Long-lived assets held in countries other than the U.S. are not considered material to the consolidated financial statements.

Major Customers

Revenue from major customers, as a percentage of consolidated revenue, is as follows:



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Customer A	22.6	%	17.6	%	29.4	%	15.4	%
Customer B	14.0	%	11.0	%	12.5	%	11.3	%
Customer C	*		*		12.3	%	10.7	%

* This customer did not account for more than 10% of revenue during this period.

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation The Company is subject to routine litigation and other claims that arise in the normal course of business. Management is not aware of any pending or threatened lawsuits or proceedings that are expected to have a material effect on the Company’s financial position, results of operations or liquidity. Concentrations and Credit Risk The majority of the Company’s revenue is derived from its Chemistry Technologies segment which consist predominantly of customers within the oil and gas industry and the sanitizer industry to a lesser extent. Customers within the oil and gas industry include oilfield services companies, integrated oil and natural gas companies, independent oil and natural gas companies, and state-owned national oil companies. Customers within the hand sanitizer industry typically include healthcare institutions such as hospitals, distributors, and various public entities. Given the increase in global demand for sanitizer products due to COVID-19, the Company's concentration of customers is shifting and diversifying, which helps to reduce credit and business risk. Customers within the sanitizer industry are not significantly impacted by commodity prices and typically are financially stable or public institutions. The Company is subject to concentrations of credit risk within trade accounts receivable, as the Company does not generally require collateral as support for trade receivables. In addition, the majority of the Company’s cash is invested in accounts in two major financial institutions and balances often exceed insurable amounts.

Related Party Transaction	6 Months Ended
Related Party Transaction	Jun. 30, 2020
Related Party Transactions [Abstract]
Related Party Transaction	Related Party Transaction In January 2017, the Internal Revenue Service (“IRS”) notified the Company that it was examining the Company’s federal tax returns for the year ended December 31, 2014. As a result of this examination, the IRS informed the Company on May 1, 2019 that certain employment taxes related to the compensation of our former CEO, Mr. Chisholm, were not properly withheld in 2014 and proposed an adjustment. Mr. Chisholm’s affiliated companies through which he provided his services have agreed to indemnify the Company for any such taxes, and Mr. Chisholm has executed a personal guaranty in favor of the Company, supporting this indemnification. At June 30, 2019, the Company recorded a liability of $2.4 million related to the estimated employment tax under-withholding for the years 2014 through 2018. By September 30, 2019, the liability totaled $1.8 million, after the Company paid $0.6 million to the IRS for these taxes and made an additional accrual covering the estimated under-withholding tax liability through 2019. In addition, at September 30, 2019 the Company recorded a receivable from the affiliated companies totaling $2.4 million. In October 2019, an amendment to the employment agreement was executed, giving the Company the contractual right of offset for any amounts owed to the Company, and giving the Company the right to withhold payments equal to amounts reasonably estimated to potentially become due to the Company by the affiliated companies from any amounts owed under the employment agreement. During the three months ended March 31, 2020, an additional accrual was recorded for $0.2 million related to potential penalties and interest on the IRS obligation. As of June 30, 2020, the receivable from Mr. Chisholm was $1.4 million, which is equal to the payable to the IRS and was netted with Mr. Chisholm’s severance liability. Both the IRS and severance liabilities are recorded in accrued liabilities on the consolidated balance sheet. On January 5, 2020, Mr. Chisholm ceased to be an employee of the Company.

Revision of Prior Financial Statements

6 Months Ended

Jun. 30, 2020

Accounting Changes and Error Corrections [Abstract]

Revision of Prior Financial Statements

During preparation of June 30, 2020 financial statements, two additional errors impacting the prior financial statements were identified, as follows:


•	Currency Translation Adjustment and Other Comprehensive Income of $1.1 million was not recognized in earnings in connection with the dissolution of the Company’s wholly owned foreign entity, PetroValve International in 2015.


•	Cash flow presentation relating to proceeds received from the sale of FCC (which occurred in the first quarter of 2019) and subsequent release of escrow amounts in subsequent periods that were improperly classified between operating and investing activities.



	As of December 31, 2018
	As previously reported			Revisions			As revised
Accumulated other comprehensive loss	$	(1,116	)	$	1,147		$	31
Retained earnings (accumulated deficit)	(107,176		)	(1,147		)	(108,323		)



	As of March 31, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(1,022	)	$	1,147		$	125
Retained earnings (accumulated deficit)	(76,314		)	(1,147		)	(77,461		)



	As of June 30, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(998	)	$	1,147		$	149
Retained earnings (accumulated deficit)	(90,727		)	(1,147		)	(91,874		)



	As of September 30, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(962	)	$	1,147		$	185
Retained earnings (accumulated deficit)	(101,770		)	(1,147		)	(102,917		)



	As of December 31, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(966	)	$	1,147		$	181
Retained earnings (accumulated deficit)	(141,091		)	(1,147		)	(142,238		)



	As of March 31, 2020
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(1,089	)	$	1,147		$	58
Retained earnings (accumulated deficit)	(205,058		)	(1,147		)	(206,205		)

*As previously reported numbers reflect the revised balances for each of the periods as disclosed in the period ended March 31, 2020.

Consolidated Statements of Cash Flows - The revision discussed above impacted the statement of cash flow as follows (in thousands):



	For the three months ended March 31, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(18,661	)	$	14,219		$	(4,442	)
Other long-term assets	—			3,286			3,286
Net cash used in operating activities	(25,721		)	17,505			(8,216		)
Proceeds from sale of business	169,722			(17,505		)	152,217
Net cash provided by investing activities	169,290			(17,505		)	151,785



	For the six months ended June 30, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(16,209	)	$	14,219		$	(1,990	)
Other long-term assets	—			3,286			3,286
Net cash used in operating activities	(23,849		)	17,505			(6,344		)
Proceeds from sale of business	169,722			(17,505		)	152,217
Net cash provided by investing activities	168,868			(17,505		)	151,363



	For the nine months ended September 30, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(14,974	)	$	10,938		$	(4,036	)
Other long-term assets	—			3,286			3,286
Net cash used in operating activities	(14,348		)	14,224			(124		)
Proceeds from sale of business	169,722			(14,224		)	155,498
Net cash provided by investing activities	167,497			(14,224		)	153,273



	For the year ended December 31, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(8,359	)	$	10,938		$	2,579
Other long-term assets	1,131			3,286			4,417
Net cash used in operating activities	(18,769		)	14,224			(4,545		)
Proceeds from sale of business	169,722			(14,224		)	155,498
Net cash provided by investing activities	166,937			(14,224		)	152,713



	For the three months ended March 31, 2020
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	6,926		$	(3,281	)	$	3,645
Net cash used in operating activities	(20,496		)	(3,281		)	(23,777		)
Proceeds from sale of business	—			3,281			3,281
Net cash provided by investing activities	41			3,281			3,322

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events In April 2020, the Company was notified by the NYSE that the average closing stock price had fallen below the continued listing standard of a share price of $1.00 (measured over a 30 day trading average). The Company had until October 2020 (later extended to December 2020) to cure the deficiency. On July 1, 2020, the Company was notified by the NYSE that the deficiency had been cured, and the noncompliance indicator was removed from the Company’s common shares. On July 28, 2020, the Company received a $6.3 million tax refund, including $0.2 million of interest, pursuant to the CARES Act that extended NOL carryback provisions related to the filing of Form 1139 requesting a refund as a result of an analysis related to the extended NOL carryback provision.

Organization and Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

2019 (“2019Annual Report”)

Use of Estimates

Reclassifications

Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did not impact previously reported net loss and stockholders’ equity.

Recent accounting pronouncements

Recent Accounting Pronouncements

Application of New Accounting Standards

New Accounting Requirements and Disclosures

New Accounting Standards to be Adopted

Earnings (loss) per share

Earnings (Loss) Per Share

Fair value measurements

Fair Value Measurements


•	Level 1 — Quoted prices in active markets for identical assets or liabilities;


•	Level 2 — Observable inputs other than Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

•

Level 3 — Significant unobservable inputs that are supported by little or no market activity or that are based on the reporting entity’s assumptions about the inputs.

Segment Information

The Chemistry Technologies segment includes specialty chemistries and logistics which enable its customers to pursue improved efficiencies in the drilling and completion of their wells.

Acquisition of JP3 Measurement LLC (Tables)

6 Months Ended

Jun. 30, 2020

Business Combinations [Abstract]

Schedule of business acquisitions, by acquisition

The following table summarizes the fair value of JP3’s assets acquired as of the closing date of May 18, 2020 (in thousands) :



Tradenames and trademarks	$	1,100
Technology and know-how	5,000
Customer relationships	6,800
Inventory	7,100
Cash	604
Net working capital, net of cash and inventory	(1,063		)
Fixed assets	426
Long-term debt assumed and other assets (liabilities)	(893		)
Goodwill	17,522
Net assets acquired	$	36,596

Discontinued Operations (Tables)

6 Months Ended

Jun. 30, 2020

Discontinued Operations and Disposal Groups [Abstract]

Summary of financial information has been segregated from continuing operations



	Three months ended June 30,					Six months ended June 30,
	2020		2019			2020		2019
Consumer and Industrial Chemistry Technologies
Revenue	$	—	$	—		$	—	$	10,877
Operating expenses	—		—			—		(11,447		)
Research and development	—		—			—		(69		)
(Loss) income from operations	—		—			—		(639		)
Other income	—		—			—		35
Gain on sale of business	—		(2,100		)	—		64,934
(Loss) Income before income taxes	—		(2,100		)	—		64,330
Income tax benefit (expense)	—		492			—		(19,864		)
Net (loss) income from discontinued operations	$	—	$	(1,608	)	$	—	$	44,466

Leases (Tables)

6 Months Ended

Jun. 30, 2020

Leases [Abstract]

Schedule of components of lease expense and supplemental cash flow information

The components of lease expense and supplemental cash flow information are as follows (in thousands):



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Operating lease expense	$	283	$	653	$	854	$	1,306
Finance lease expense:
Amortization of right-of-use assets	4		220		9		220
Interest on lease liabilities	5		3		9		3
Total finance lease expense	9		223		18		223
Short-term lease expense	54		32		86		75
Total lease expense	$	346	$	908	$	958	$	1,604

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	1,411	$	583	$	1,024	$	1,165
Operating cash flows from finance leases	5		3		9		3
Financing cash flows from finance leases	14		38		51		38

Schedule of maturities of lease liabilities

Maturities of lease liabilities are as follows (in thousands):



Years ending December 31,	Operating Leases			Finance Leases
2020 (excluding the six months ended June 30, 2020)	$	617		$	33
2021	1,330			70
2022	1,283			47
2023	1,311			39
2024	1,341			23
Thereafter	8,185			—
Total lease payments	$	14,067		$	212
Less: Interest	(4,916		)	(28		)
Present value of lease liabilities	$	9,151		$	184

Schedule of maturities of lease liabilities

Maturities of lease liabilities are as follows (in thousands):



Years ending December 31,	Operating Leases			Finance Leases
2020 (excluding the six months ended June 30, 2020)	$	617		$	33
2021	1,330			70
2022	1,283			47
2023	1,311			39
2024	1,341			23
Thereafter	8,185			—
Total lease payments	$	14,067		$	212
Less: Interest	(4,916		)	(28		)
Present value of lease liabilities	$	9,151		$	184

Schedule of supplemental balance sheet information

Supplemental balance sheet information related to leases is as follows (in thousands):



	June 30, 2020			December 31, 2019
Operating Leases
Operating lease right-of-use assets	$	2,422		$	16,388

Current portion of operating lease liabilities	$	654		$	486
Long-term operating lease liabilities	8,497			16,973
Total operating lease liabilities	$	9,151		$	17,459

Finance Leases
Property and equipment	$	147		$	293
Accumulated depreciation	(18		)	(28		)
Property and equipment, net	$	129		$	265

Current portion of finance lease liabilities	$	57		$	55
Long-term finance lease liabilities	127			158
Total finance lease liabilities	$	184		$	213

Weighted Average Remaining Lease Term
Operating leases	10.1 years			16.6 years
Finance leases	4.1 years			4.6 years

Weighted Average Discount Rate
Operating leases	8.9		%	8.9		%
Finance leases	8.5		%	9.0		%

Revenue from Contracts with Customers (Tables)

6 Months Ended

Jun. 30, 2020

Revenue from Contract with Customer [Abstract]

Schedule of disaggregation of revenue

Revenue and operating expenses (excluding depreciation and amortization) disaggregated by revenue source are as follows (in thousands):



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Revenue:
Products	$	8,176	$	33,632	$	26,976	$	75,703
Services	704		1,060		1,320		2,246
	$	8,880	$	34,692	$	28,296	$	77,949
Operating expenses (excluding depreciation and amortization):
Products	$	11,278	$	37,613	$	33,825	$	81,062
Services	354		508		648		1,027
	$	11,632	$	38,121	$	34,473	$	82,089

Supplemental Cash Flow Information (Tables)

6 Months Ended

Jun. 30, 2020

Supplemental Cash Flow Elements [Abstract]

Components of supplemental cash flow information

Supplemental cash flow information is as follows (in thousands):



	Six months ended June 30,
	2020		2019
Supplemental cash payment information:
Interest paid	$	20	$	594
Income taxes paid, net of refunds	149		627
Supplemental schedule of non-cash investing and financing activities:
Equity issued - acquisition of JP3	8,538		—

Inventories (Tables)

6 Months Ended

Jun. 30, 2020

Inventory Disclosure [Abstract]

Schedule of components of inventory

Inventories are as follows (in thousands):



	June 30, 2020			December 31, 2019
Raw materials	$	4,810		$	4,339
Finished goods	20,155			24,569
Inventories	24,965			28,908
Less reserve for excess and obsolete inventory	(1,627		)	(5,698		)
Inventories, net	$	23,338		$	23,210

Property and Equipment (Tables)

6 Months Ended

Jun. 30, 2020

Property, Plant and Equipment [Abstract]

Components of property and equipment

Property and equipment are as follows (in thousands):



	June 30, 2020			December 31, 2019
Land	$	3,282		$	4,440
Buildings and leasehold improvements	6,048			38,741
Machinery and equipment	7,227			27,694
Furniture and fixtures	643			1,671
Transportation equipment	1,190			1,440
Computer equipment and software	1,296			3,348
Property and equipment	19,686			77,334
Less accumulated depreciation	(11,669		)	(37,505		)
Property and equipment, net	$	8,017		$	39,829

Impairment of Fixed and Long-lived Assets (Tables)

6 Months Ended

Jun. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of impairment charges

The Company recorded impairment charges during the six months ended June 30, 2020 as follows (in thousands):



Property and equipment, net	$	30,178
Operating lease right-of-use assets	7,434

Other Intangibles:
Patents	9,902
Customer Lists	9,165
Intangibles assets in progress	596
Trademarks and brand names	179
Total Other Intangibles	19,842

Total Impairment of fixed and long-lived assets	$	57,454

Goodwill (Tables)

6 Months Ended

Jun. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

Goodwill associated with the acquisition of JP3 on May 18, 2020 is as follows (in thousands):



Goodwill at December 31, 2019	$	—
Goodwill from acquisition of JP3	17,522
Goodwill at June 30, 2020	$	17,522

Other Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of other intangible assets

Other intangible assets are as follows (in thousands):



	June 30, 2020				December 31, 2019
	Cost		Accumulated Amortization		Cost		Accumulated Amortization
Finite-lived intangible assets:
Patents and technology	$	5,000	$	55	$	17,493	$	6,715
Customer lists	6,800		55		15,367		6,013
Trademarks and brand names	1,100		13		1,351		1,160
Total finite-lived intangible assets	$	12,900	123		$	34,211	13,888

Carrying value:
Other intangible assets, net	$	12,777			$	20,323

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurements, Recurring



							Balance at June 30,								Balance at December 31,
	Level 1		Level 2		Level 3		2020		Level 1		Level 2		Level 3		2019
Contingent consideration	$	—	$	—	$	1,200	$	1,200	$	—	$	—	$	—	$	—

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

following table presents the changes in contingent consideration balances classified as Level 3 balances for the three and six months ended June 30, 2020 and 2019:



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Balance - beginning of period	$	—	$	—	$	—	$	—
Additions / issuances	1,200		—		1,200		—
Gains (losses) recognized in earnings	—		—		—		—
Payments	—		—		—		—
Balance - end of period	$	1,200	$	—	$	1,200	$	—

Debt Debt (Tables)

6 Months Ended

Jun. 30, 2020

Debt Disclosure [Abstract]

Schedule of Debt

Long-term debt, including current portion is as follows (in thousands):



	June 30, 2020
Current Portion of Long-Term Debt
Flotek PPP Loan	$	2,138
JP3 PPP Loan	389
Total current portion of long-term debt	$	2,527

Long-term debt:
Flotek PPP Loan	$	2,660
JP3 PPP Loan	484
Total long-term debt	$	3,144

Income Taxes (Tables)

6 Months Ended

Jun. 30, 2020

Income Tax Disclosure [Abstract]

Reconciliation of effective tax rate to the U.S. federal statutory tax rate

A reconciliation of the U.S. federal statutory tax rate to the Company’s effective income tax rate is as follows:



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
U.S. federal statutory tax rate	21.0	%	21.0	%	21.0	%	21.0	%
State income taxes, net of federal benefit	0.4		1.7		—		1.0
Non-U.S. income taxed at different rates	0.9		0.7		0.2		1.0
Reduction in tax benefit related to stock-based awards	0.9		(1.1	)	(0.1	)	(1.8	)
Non-deductible expenses	0.7		—		—		(0.3	)
Research and development credit	0.1		0.4		—		0.6
Increase in valuation allowance	(23.7	)	(20.7	)	(16.0	)	(17.9	)
Effect of tax rate differences of NOL carryback	—		—		2.6		—
Other	—		(0.4	)	—		(0.3	)
Effective income tax rate	0.3	%	1.6	%	7.7	%	3.3	%

Common Stock (Tables)

6 Months Ended

Jun. 30, 2020

Equity [Abstract]

Schedule of reconciliation of changes in common shares issued

A reconciliation of changes in common shares issued during the six months ended June 30, 2020 is as follows:



Shares issued at December 31, 2019	63,656,897
Issued to purchase JP3	11,500,000
Issued as restricted stock award grants	2,469,238
Shares issued at June 30, 2020	77,626,135

Business Segment, Geographic and Major Customer Information (Tables)

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

Summary of financial information regarding reportable segments

Summarized financial information of the reportable segments is as follows (in thousands):



For the three months ended June 30,	Chemistry Technologies			Data Analytics⁽¹⁾			Corporate and Other			Total
2020
Net revenue from external customers	$	7,962		$	918		$	—		$	8,880
Loss from operations, including impairment	(3,596		)	(1,151		)	(5,484		)	(10,231		)
Depreciation and amortization	246			131			91			468
Capital expenditures	—			—			—			—

2019
Net revenue from external customers	$	34,692		$	—		$	—		$	34,692
Loss from operations	(7,651		)	—			(6,023		)	(13,674		)
Depreciation and amortization	1,933			—			186			2,119
Capital expenditures	306			—			—			306



For the six months ended June 30,	Chemistry Technologies			Data Analytics⁽¹⁾			Corporate and Other			Total
2020
Net revenue from external customers	$	27,378		$	918		$	—		$	28,296
Loss from operations, including impairment	(66,257		)	(1,151		)	(12,908		)	(80,316		)
Depreciation and amortization	2,056			131			472			2,659
Capital expenditures	42			—			—			42

2019
Net revenue from external customers	$	77,949		$	—		$	—		$	77,949
Loss from operations	(12,984		)	—			(14,323		)	(27,307		)
Depreciation and amortization	3,718			—			661			4,379
Capital expenditures	767			—			—			767

⁽¹⁾The financial information disclosed above for Data Analytics is for the period May 18, 2020 to June 30, 2020.

Assets of the Company by reportable segments are as follows (in thousands):



	June 30, 2020		December 31, 2019
Chemistry Technologies	$	34,439	$	116,110
Data Analytics	40,922		—
Corporate and Other	66,835		114,490
Total assets	$	142,196	$	230,600

Schedule of revenue by geographic location

Revenue by geographic location is as follows (in thousands):



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
U.S.	$	6,936	$	31,114	$	22,711	$	69,990
Other countries	1,944		3,578		5,585		7,959
Total	$	8,880	$	34,692	$	28,296	$	77,949

Schedule of revenue by major customer

Revenue from major customers, as a percentage of consolidated revenue, is as follows:



	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Customer A	22.6	%	17.6	%	29.4	%	15.4	%
Customer B	14.0	%	11.0	%	12.5	%	11.3	%
Customer C	*		*		12.3	%	10.7	%

* This customer did not account for more than 10% of revenue during this period.

Revision of Prior Financial Statements (Tables)

6 Months Ended

Jun. 30, 2020

Accounting Changes and Error Corrections [Abstract]

Schedule of impacted financial statements



	As of December 31, 2018
	As previously reported			Revisions			As revised
Accumulated other comprehensive loss	$	(1,116	)	$	1,147		$	31
Retained earnings (accumulated deficit)	(107,176		)	(1,147		)	(108,323		)



	As of March 31, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(1,022	)	$	1,147		$	125
Retained earnings (accumulated deficit)	(76,314		)	(1,147		)	(77,461		)



	As of June 30, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(998	)	$	1,147		$	149
Retained earnings (accumulated deficit)	(90,727		)	(1,147		)	(91,874		)



	As of September 30, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(962	)	$	1,147		$	185
Retained earnings (accumulated deficit)	(101,770		)	(1,147		)	(102,917		)



	As of December 31, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(966	)	$	1,147		$	181
Retained earnings (accumulated deficit)	(141,091		)	(1,147		)	(142,238		)



	As of March 31, 2020
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(1,089	)	$	1,147		$	58
Retained earnings (accumulated deficit)	(205,058		)	(1,147		)	(206,205		)

*As previously reported numbers reflect the revised balances for each of the periods as disclosed in the period ended March 31, 2020.

Consolidated Statements of Cash Flows - The revision discussed above impacted the statement of cash flow as follows (in thousands):



	For the three months ended March 31, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(18,661	)	$	14,219		$	(4,442	)
Other long-term assets	—			3,286			3,286
Net cash used in operating activities	(25,721		)	17,505			(8,216		)
Proceeds from sale of business	169,722			(17,505		)	152,217
Net cash provided by investing activities	169,290			(17,505		)	151,785



	For the six months ended June 30, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(16,209	)	$	14,219		$	(1,990	)
Other long-term assets	—			3,286			3,286
Net cash used in operating activities	(23,849		)	17,505			(6,344		)
Proceeds from sale of business	169,722			(17,505		)	152,217
Net cash provided by investing activities	168,868			(17,505		)	151,363



	For the nine months ended September 30, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(14,974	)	$	10,938		$	(4,036	)
Other long-term assets	—			3,286			3,286
Net cash used in operating activities	(14,348		)	14,224			(124		)
Proceeds from sale of business	169,722			(14,224		)	155,498
Net cash provided by investing activities	167,497			(14,224		)	153,273



	For the year ended December 31, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(8,359	)	$	10,938		$	2,579
Other long-term assets	1,131			3,286			4,417
Net cash used in operating activities	(18,769		)	14,224			(4,545		)
Proceeds from sale of business	169,722			(14,224		)	155,498
Net cash provided by investing activities	166,937			(14,224		)	152,713



	For the three months ended March 31, 2020
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	6,926		$	(3,281	)	$	3,645
Net cash used in operating activities	(20,496		)	(3,281		)	(23,777		)
Proceeds from sale of business	—			3,281			3,281
Net cash provided by investing activities	41			3,281			3,322

Organization and Significant Accounting Policies (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Mar. 30, 2020	Dec. 31, 2020
JP3 Measurement, LLC
Unusual or Infrequent Item, or Both
Ownership (in percentage)	100.00%
Aggregate value of consideration paid	$ 36.6
Payments to acquire business	$ 25.0
Shares issued to acquire business (in shares)	11.5
Fair value of shares used as consideration	$ 8.5
Excess working capital assumed	1.9
Contingent consideration	1.2
Additional earn-out based on appreciation of Flotek’s share price	$ 5.0
COVID-19 pandemic
Unusual or Infrequent Item, or Both
Reduction headcount (percentage)		35.00%
Forecast \| COVID-19 pandemic \| Chief Executive Officer
Unusual or Infrequent Item, or Both
Compensation reduction (percentage)			20.00%
Forecast \| COVID-19 pandemic \| Executive Officers
Unusual or Infrequent Item, or Both
Compensation reduction (percentage)			10.00%
Forecast \| COVID-19 pandemic \| Board Of Directors
Unusual or Infrequent Item, or Both
Compensation reduction (percentage)			20.00%

Acquisition of JP3 Measurement LLC - Narrative (Details) shares in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2020 USD ($) shares	Jun. 30, 2020 USD ($)
Business Acquisition
Business acquisition costs	$ 500,000	$ 500
JP3 Measurement, LLC
Business Acquisition
Ownership (in percentage)	100.00%	100.00%
Aggregate value of consideration paid	$ 36,600,000
Payments to acquire business	$ 25,000,000.0
Shares issued to acquire business (in shares) \| shares	11.5
Fair value of shares used as consideration	$ 8,500,000
Excess working capital assumed	1,900,000
Contingent consideration	1,200,000
Additional earn-out based on appreciation of Flotek’s share price	$ 5,000,000.0

Acquisition of JP3 Measurement LLC - Net Assets Acquired (Details) - USD ($) $ in Thousands	Jun. 30, 2020	May 18, 2020	Dec. 31, 2019
Assets acquired:
Goodwill	$ 17,522		$ 0
JP3 Measurement, LLC
Assets acquired:
Inventory		$ 7,100
Cash		604
Net working capital, net of cash and inventory		(1,063)
Fixed assets, net		426
Long-term debt assumed and other assets (liabilities)		(893)
Goodwill	$ 17,522	17,522	$ 0
Net assets acquired		36,596
JP3 Measurement, LLC \| Tradenames and Trademarks
Assets acquired:
Intangible assets other than goodwill		1,100
JP3 Measurement, LLC \| Technology and know-how
Assets acquired:
Intangible assets other than goodwill		5,000
JP3 Measurement, LLC \| Customer relationships
Assets acquired:
Intangible assets other than goodwill		$ 6,800

Discontinued Operations - Additional Disclosures (Details) - USD ($) $ in Millions			3 Months Ended		6 Months Ended	12 Months Ended
	Feb. 26, 2020	Feb. 28, 2019	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations
Payment for amendment agreement	$ 15.8
Escrow deposit released			$ 6.6	$ 3.3
Consumer and Industrial Chemistry Technologies \| Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations
Cash consideration		$ 175.0
Working Adjustment Period 1 \| Consumer and Industrial Chemistry Technologies \| Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations
Contingent liabilities remaining		$ 4.4
Contingent liabilities remaining period		90 days
Loss on contract settlement						$ 19.0
Working Adjustment Period 2-4 \| Consumer and Industrial Chemistry Technologies \| Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations
Contingent liabilities remaining		$ 13.1
Working Adjustment Period 2 \| Consumer and Industrial Chemistry Technologies \| Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations
Contingent liabilities remaining period		6 months
Working Adjustment Period 3 \| Consumer and Industrial Chemistry Technologies \| Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations
Contingent liabilities remaining period		12 months
Working Adjustment Period 4 \| Consumer and Industrial Chemistry Technologies \| Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations
Contingent liabilities remaining period		15 months
Amended terpene supply agreement
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations
Additional loss					$ 0.8

Discontinued Operations - Summary Of Financial Information That Has Been Segregated From Continuing Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations
Net (loss) income from discontinued operations	$ 0	$ (1,608)	$ 0	$ 44,466
Consumer and Industrial Chemistry Technologies \| Discontinued Operations, Held-for-sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations
Revenue	0	0	0	10,877
Operating expenses	0	0	0	(11,447)
Research and development	0	0	0	(69)
(Loss) income from operations	0	0	0	(639)
Other income	0	0	0	35
Gain on sale of business	0	(2,100)	0	64,934
(Loss) Income before income taxes	0	(2,100)	0	64,330
Income tax benefit (expense)	0	492	0	(19,864)
Net (loss) income from discontinued operations	$ 0	$ (1,608)	$ 0	$ 44,466

Leases - Additional Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Leases [Abstract]
Accounting Standards Update [Extensible List]					us-gaap:AccountingStandardsUpdate201602Member
Adjustments to operating lease right of use asset		$ 6,200
Adjustments to operating lease liability		6,200
Lease ROU impairment		$ 7,400		$ 7,434
Payment to terminate lease	$ 1,000
Gain on lease termination	$ 576		$ 0	$ 576	$ 0

Leases - Components of Lease Expense and Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Leases [Abstract]
Operating lease expense	$ 283	$ 653	$ 854	$ 1,306
Amortization of right-of-use assets	4	220	9	220
Interest on lease liabilities	5	3	9	3
Total finance lease expense	9	223	18	223
Short-term lease expense	54	32	86	75
Total lease expense	346	908	958	1,604
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	1,411	583	1,024	1,165
Operating cash flows from finance leases	5	3	9	3
Financing cash flows from finance leases	$ 14	$ 38	$ 51	$ 38

Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Operating Leases
2020 (excluding the six months ended June 30, 2020)	$ 617
2021	1,330
2022	1,283
2023	1,311
2024	1,341
Thereafter	8,185
Total lease payments	14,067
Less: Interest	(4,916)
Present value of lease liabilities	9,151	$ 17,459
Finance Leases
2020 (excluding the six months ended June 30, 2020)	33
2021	70
2022	47
2023	39
2024	23
Thereafter	0
Total lease payments	212
Less: Interest	(28)
Present value of lease liabilities	$ 184	$ 213

Leases - Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Operating Leases
Operating lease right-of-use assets	$ 2,422	$ 16,388
Current portion of operating lease liabilities	654	486
Long-term operating lease liabilities	8,497	16,973
Total operating lease liabilities	9,151	17,459
Finance Leases
Property and equipment	147	293
Accumulated depreciation	(18)	(28)
Property and equipment, net	$ 129	$ 265
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
Current portion of finance lease liabilities	$ 57	$ 55
Long-term finance lease liabilities	127	158
Total finance lease liabilities	$ 184	$ 213
Weighted Average Remaining Lease Term
Operating leases (in years)	10 years 1 month 6 days	16 years 7 months 6 days
Finance leases (in years)	4 years 1 month 6 days	4 years 7 months 6 days
Weighted Average Discount Rate
Operating leases (in percentage)	8.90%	8.90%
Finance leases (in percentage)	8.50%	9.00%

Revenue from Contracts with Customers (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenue from Contract with Customer [Abstract]
Product sales as a percentage of total revenue (in percentage)	90.00%	90.00%	90.00%	90.00%
Disaggregation of Revenue
Revenue	$ 8,880	$ 34,692	$ 28,296	$ 77,949
Operating expenses (excluding depreciation and amortization):	11,632	38,121	34,473	82,089
Products
Disaggregation of Revenue
Revenue	8,176	33,632	26,976	75,703
Operating expenses (excluding depreciation and amortization):	11,278	37,613	33,825	81,062
Services
Disaggregation of Revenue
Revenue	704	1,060	1,320	2,246
Operating expenses (excluding depreciation and amortization):	$ 354	$ 508	$ 648	$ 1,027

Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2020	Jun. 30, 2019
Supplemental cash payment information:
Interest paid		$ 20	$ 594
Income taxes paid, net of refunds		149	627
Supplemental schedule of non-cash investing and financing activities:
Equity issued - acquisition of JP3	$ 8,538	$ 8,538	$ 0

Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 4,810	$ 4,339
Finished goods	20,155	24,569
Inventories	24,965	28,908
Less reserve for excess and obsolete inventory	(1,627)	(5,698)
Inventories, net	$ 23,338	$ 23,210

Property and Equipment - Components of Property and Equipment (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Components of Property, Plant and Equipment
Property and equipment	$ 19,686	$ 77,334
Less accumulated depreciation	(11,669)	(37,505)
Property and equipment, net	$ 8,017	$ 39,829
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
Land
Components of Property, Plant and Equipment
Property and equipment	$ 3,282	$ 4,440
Buildings and leasehold improvements
Components of Property, Plant and Equipment
Property and equipment	6,048	38,741
Machinery and equipment
Components of Property, Plant and Equipment
Property and equipment	7,227	27,694
Furniture and fixtures
Components of Property, Plant and Equipment
Property and equipment	643	1,671
Transportation equipment
Components of Property, Plant and Equipment
Property and equipment	1,190	1,440
Computer equipment and software
Components of Property, Plant and Equipment
Property and equipment	$ 1,296	$ 3,348

Property and Equipment - Additional Disclosures (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 300,000	$ 1,600,000	$ 2,000,000.0	$ 3,400,000
Property and equipment	$ 0		$ 30,178,000

Impairment of Fixed and Long-lived Assets (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2020 USD ($) segment
Goodwill and Intangible Assets Disclosure [Abstract]
Impairment of fixed and long lived \| $	$ 57,454
Number of reportable segments (segment) \| segment	2

Impairment of Fixed and Long-lived Assets - Schedule of Impairment Charges (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2020	Jun. 30, 2019
Long Lived Assets Held-for-sale
Property and equipment, net	$ 0		$ 30,178,000
Operating lease right-of-use assets		$ 7,400,000	7,434,000
Total Other Intangibles			19,842,000	$ 0
Impairment of fixed and long lived			57,454,000
Patents
Long Lived Assets Held-for-sale
Total Other Intangibles			9,902,000
Customer lists
Long Lived Assets Held-for-sale
Total Other Intangibles			9,165,000
Intangibles assets in progress
Long Lived Assets Held-for-sale
Total Other Intangibles			596,000
Trademarks and brand names
Long Lived Assets Held-for-sale
Total Other Intangibles			$ 179,000

Goodwill (Details) $ in Thousands	6 Months Ended
Goodwill (Details) $ in Thousands	Jun. 30, 2020 USD ($)
Goodwill
Goodwill at December 31, 2019	$ 0
Goodwill at June 30, 2020	17,522
JP3 Measurement, LLC
Goodwill
Goodwill at December 31, 2019	0
Goodwill from acquisition of JP3	17,522
Goodwill at June 30, 2020	$ 17,522

Other Intangible Assets - Schedule of Other Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets
Finite-lived intangible assets, cost	$ 12,900	$ 34,211
Finite-lived intangible assets, accumulated amortization	123	13,888
Other intangible assets, net	12,777	20,323
Patents and technology
Finite-Lived Intangible Assets
Finite-lived intangible assets, cost	5,000	17,493
Finite-lived intangible assets, accumulated amortization	55	6,715
Customer lists
Finite-Lived Intangible Assets
Finite-lived intangible assets, cost	6,800	15,367
Finite-lived intangible assets, accumulated amortization	55	6,013
Trademarks and brand names
Finite-Lived Intangible Assets
Finite-lived intangible assets, cost	1,100	1,351
Finite-lived intangible assets, accumulated amortization	$ 13	$ 1,160

Other Intangible Assets - Additional Disclosures (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of finite-lived intangible assets	$ 0.1	$ 0.5

Earnings (Loss) Per Share - Additional Disclosures (Details) - shares shares in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share
Anti-dilutive securities excluded from calculation of earnings per share (in shares)	0.4	0.7		0.7
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share
Anti-dilutive securities excluded from calculation of earnings per share (in shares)			4.0

Fair Value Measurements - Additional Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2020	Jun. 30, 2020
Assets Measured at Fair Value on a Nonrecurring Basis [Line Items]
Impairment of fixed and long lived		$ 57,454
Nonrecurring
Assets Measured at Fair Value on a Nonrecurring Basis [Line Items]
Impairment of fixed and long lived	$ 57,500
Level 3 \| Nonrecurring
Assets Measured at Fair Value on a Nonrecurring Basis [Line Items]
Long-term debt fair value		900
Level 3 \| JP3 Measurement, LLC
Assets Measured at Fair Value on a Nonrecurring Basis [Line Items]
Contingent consideration asset		$ 1,200

Fair Value Measurements - Recurring (Details) - Recurring - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring
Contingent consideration	$ 1,200	$ 0
Level 1
Fair Value, Assets and Liabilities Measured on Recurring
Contingent consideration	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring
Contingent consideration	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring
Contingent consideration	$ 1,200	$ 0

Fair Value Measurements - Rollforward (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Balance - beginning of period	$ 0	$ 0	$ 0	$ 0
Additions / issuances	1,200	0	1,200	0
Gains (losses) recognized in earnings	0	0	0	0
Payments	0	0	0	0
Balance - end of period	$ 1,200	$ 0	$ 1,200	$ 0

Debt (Details) - USD ($) $ in Millions		1 Months Ended
Debt (Details) - USD ($) $ in Millions	May 18, 2020	Apr. 30, 2020
Unsecured Debt \| PPP
Debt Instrument
Proceeds from debt		$ 4.8
Debt instrument stated interest rate (percent)		1.00%
Percentage of cost allocable to payroll costs (percent)		60.00%
JP3 Measurement, LLC
Debt Instrument
Assumed PPP loan	$ 0.9

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Debt Instrument
Current portion of long-term debt	$ 2,527	$ 0
Long-term debt, less current portion	3,144	$ 0
Unsecured Debt
Debt Instrument
Current portion of long-term debt	2,527
Long-term debt, less current portion	3,144
Unsecured Debt \| Flotek PPP Loan
Debt Instrument
Current portion of long-term debt	2,138
Long-term debt, less current portion	2,660
Unsecured Debt \| JP3 PPP Loan
Debt Instrument
Current portion of long-term debt	389
Long-term debt, less current portion	$ 484

Income Taxes - Reconciliation of Effective Tax Rate (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Tax Disclosure [Abstract]
U.S. federal statutory tax rate	21.00%	21.00%	21.00%	21.00%
State income taxes, net of federal benefit	0.40%	1.70%	0.00%	1.00%
Non-U.S. income taxed at different rates	0.90%	0.70%	0.20%	1.00%
Reduction in tax benefit related to stock-based awards	0.90%	(1.10%)	(0.10%)	(1.80%)
Non-deductible expenses	0.70%	0.00%	0.00%	(0.30%)
Research and development credit	0.10%	0.40%	0.00%	0.60%
Increase in valuation allowance	(23.70%)	(20.70%)	(16.00%)	(17.90%)
Effect of tax rate differences of NOL carryback	0.00%	0.00%	2.60%	0.00%
Other	0.00%	(0.40%)	0.00%	(0.30%)
Effective income tax rate	0.30%	1.60%	7.70%	3.30%

Income Taxes - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
Income Taxes - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2019	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Taxes receivable		$ 6.1
Valuation allowance	$ 19.9
Decrease in valuation allowance	$ 4.0

Common Stock - Reconciliation of Changes in Common Shares Issued and Additional Disclosures (Details) - $ / shares	6 Months Ended
	Jun. 30, 2020	May 05, 2020	May 04, 2020	Dec. 31, 2019
Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]
Common stock, shares authorized (in shares)	140,000,000	140,000,000	80,000,000	140,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001		$ 0.0001
Preferred stock, shares authorized (in shares)	100,000	100,000		100,000
Preferred stock, at par value (in dollars per share)	$ 0.0001	$ 0.0001		$ 0.0001
Reconciliation of changes in common shares issued
Shares issued at December 31, 2019	63,656,897
Issued to purchase JP3	11,500,000
Issued as restricted stock award grants	2,469,238
Shares issued at June 30, 2020	77,626,135

Business Segment, Geographic and Major Customer Information - Additional Disclosures (Details)	6 Months Ended
	Jun. 30, 2020 segment
Segment Reporting [Abstract]
Number of reportable segments (segment)	2

Business Segment, Geographic and Major Customer Information - Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Summarized financial information regarding reportable segments
Net revenue from external customers	$ 8,880	$ 34,692	$ 28,296	$ 77,949
Loss from operations, including impairment	(10,231)	(13,674)	(80,316)	(27,307)
Depreciation and amortization	468	2,119	2,659	4,379
Capital expenditures	0	306	42	767
Operating Segments \| Chemistry Technologies
Summarized financial information regarding reportable segments
Net revenue from external customers	7,962	34,692	27,378	77,949
Loss from operations, including impairment	(3,596)	(7,651)	(66,257)	(12,984)
Depreciation and amortization	246	1,933	2,056	3,718
Capital expenditures	0	306	42	767
Operating Segments \| Data Analytics
Summarized financial information regarding reportable segments
Net revenue from external customers	918		918
Loss from operations, including impairment	(1,151)		(1,151)
Depreciation and amortization	131		131
Capital expenditures	0		0
Corporate and Other
Summarized financial information regarding reportable segments
Net revenue from external customers	0	0	0	0
Loss from operations, including impairment	(5,484)	(6,023)	(12,908)	(14,323)
Depreciation and amortization	91	186	472	661
Capital expenditures	$ 0	$ 0	$ 0	$ 0

Business Segment, Geographic and Major Customer Information - Assets by Reportable Segments (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Segment Reporting Information
Total assets	$ 142,196	$ 230,600
Operating Segments \| Chemistry Technologies
Segment Reporting Information
Total assets	34,439	116,110
Operating Segments \| Data Analytics
Segment Reporting Information
Total assets	40,922	0
Corporate and Other
Segment Reporting Information
Total assets	$ 66,835	$ 114,490

Business Segment, Geographic and Major Customer Information - Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenues from External Customers and Long-Lived Assets
Revenue	$ 8,880	$ 34,692	$ 28,296	$ 77,949
U.S.
Revenues from External Customers and Long-Lived Assets
Revenue	6,936	31,114	22,711	69,990
Other countries
Revenues from External Customers and Long-Lived Assets
Revenue	$ 1,944	$ 3,578	$ 5,585	$ 7,959

Business Segment, Geographic and Major Customer Information - Major Customers (Details) - Customer Concentration Risk - Sales	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Customer A
Segment Reporting Information
Percentage of revenue by major customers (in percentage)	22.60%	17.60%	29.40%	15.40%
Customer B
Segment Reporting Information
Percentage of revenue by major customers (in percentage)	14.00%	11.00%	12.50%	11.30%
Customer C
Segment Reporting Information
Percentage of revenue by major customers (in percentage)			12.30%	10.70%

Related Party Transaction (Details) - USD ($) $ in Millions	12 Months Ended
Related Party Transaction (Details) - USD ($) $ in Millions	Dec. 31, 2019	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019
Related Party Transaction
Taxes payable				$ 1.8	$ 2.4
Due from related party				$ 2.4
Accrual for potential penalties and interest			$ 0.2
Chief Executive Officer \| Affiliated Entity
Related Party Transaction
Income taxes paid	$ 0.6
Due from related party		$ 1.4

Revision of Prior Financial Statements (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2015
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net (loss) income	$ (9,561)	$ (14,413)	$ (73,528)	$ 16,449	$ (14,600)
As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net (loss) income					(13,500)
AOCI Attributable to Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Misstatement					1,100
Accumulated Foreign Currency Adjustment Attributable to Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Misstatement					$ 1,100

Revision of Prior Financial Statements - Balance Sheet Impact (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018
Balance Sheet
Accumulated other comprehensive income	$ 51	$ 58	$ 181	$ 185	$ 149	$ 125	$ 31
Retained earnings (accumulated deficit)	$ (215,766)	(206,205)	(142,238)	(102,917)	(91,874)	(77,461)	(108,323)
As previously reported
Balance Sheet
Accumulated other comprehensive income		(1,089)	(966)	(962)	(998)	(1,022)	(1,116)
Retained earnings (accumulated deficit)		(205,058)	(141,091)	(101,770)	(90,727)	(76,314)	(107,176)
Revisions
Balance Sheet
Accumulated other comprehensive income		1,147	1,147	1,147	1,147	1,147	1,147
Retained earnings (accumulated deficit)		$ (1,147)	$ (1,147)	$ (1,147)	$ (1,147)	$ (1,147)	$ (1,147)

Revision of Prior Financial Statements - Cash Flow Impact (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended		9 Months Ended	12 Months Ended
	Mar. 31, 2020	Sep. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2019	Dec. 31, 2019
Cash Flow Impact
Other current assets	$ 3,645	$ (4,036)	$ (4,442)	$ 1,715	$ (1,990)		$ 2,579
Other long-term assets		(3,286)	(3,286)	0	(3,286)		(4,417)
Net cash used in operating activities	(23,777)		(8,216)			$ (124)	(4,545)
Net cash used in operating activities				(29,216)	(6,344)
Proceeds from sale of business	3,281		152,217	9,844	152,217	155,498	155,498
Net cash used in investing activities	3,322		151,785			153,273	152,713
Net cash provided by investing activities				$ (16,424)	151,363
As previously reported
Cash Flow Impact
Other current assets	6,926	(14,974)	(18,661)		(16,209)		(8,359)
Other long-term assets		0	0		0		(1,131)
Net cash used in operating activities	(20,496)		(25,721)			(14,348)	(18,769)
Net cash used in operating activities					(23,849)
Proceeds from sale of business	0		169,722		169,722	169,722	169,722
Net cash used in investing activities	41		169,290			167,497	166,937
Net cash provided by investing activities					168,868
Revisions
Cash Flow Impact
Other current assets	(3,281)	10,938	14,219		14,219		10,938
Other long-term assets		$ (3,286)	(3,286)		(3,286)		(3,286)
Net cash used in operating activities	(3,281)		17,505			14,224	14,224
Net cash used in operating activities					17,505
Proceeds from sale of business	3,281		(17,505)		(17,505)	(14,224)	(14,224)
Net cash used in investing activities	$ 3,281		$ (17,505)			$ (14,224)	$ (14,224)
Net cash provided by investing activities					$ (17,505)

Subsequent Events (Details) - Subsequent Event [Member] $ in Millions	Jul. 28, 2020 USD ($)
Subsequent Event
Proceeds from income tax refund	$ 6.3
Interest portion of tax refund	$ 0.2